Altering cell death pathways as an approach to cure HIV infection
Recent cases of successful control of human immunodeficiency virus (HIV) by bone marrow transplant in combination with suppressive antiretroviral therapy (ART) and very early initiation of ART have provided proof of concept that HIV infection might now be cured. Current efforts focusing on gene ther...
Saved in:
Published in | Cell death & disease Vol. 4; no. 7; p. e718 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.07.2013
Springer Nature B.V Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Recent cases of successful control of human immunodeficiency virus (HIV) by bone marrow transplant in combination with suppressive antiretroviral therapy (ART) and very early initiation of ART have provided proof of concept that HIV infection might now be cured. Current efforts focusing on gene therapy, boosting HIV-specific immunity, reducing inflammation and activation of latency have all been the subject of recent excellent reviews. We now propose an additional avenue of research towards a cure for HIV: targeting HIV apoptosis regulatory pathways. The central enigma of HIV disease is that HIV infection kills most of the CD4 T cells that it infects, but those cells that are spared subsequently become a latent reservoir for HIV against which current medications are ineffective. We propose that if strategies could be devised which would favor the death of all cells which HIV infects, or if all latently infected cells that release HIV would succumb to viral-induced cytotoxicity, then these approaches combined with effective ART to prevent spreading infection, would together result in a cure for HIV. This premise is supported by observations in other viral systems where the relationship between productive infection, apoptosis resistance, and the development of latency or persistence has been established. Therefore we propose that research focused at understanding the mechanisms by which HIV induces apoptosis of infected cells, and ways that some cells escape the pro-apoptotic effects of productive HIV infection are critical to devising novel and rational approaches to cure HIV infection. |
---|---|
AbstractList | Recent cases of successful control of human immunodeficiency virus (HIV) by bone marrow transplant in combination with suppressive antiretroviral therapy (ART) and very early initiation of ART have provided proof of concept that HIV infection might now be cured. Current efforts focusing on gene therapy, boosting HIV-specific immunity, reducing inflammation and activation of latency have all been the subject of recent excellent reviews. We now propose an additional avenue of research towards a cure for HIV: targeting HIV apoptosis regulatory pathways. The central enigma of HIV disease is that HIV infection kills most of the CD4 T cells that it infects, but those cells that are spared subsequently become a latent reservoir for HIV against which current medications are ineffective. We propose that if strategies could be devised which would favor the death of all cells which HIV infects, or if all latently infected cells that release HIV would succumb to viral-induced cytotoxicity, then these approaches combined with effective ART to prevent spreading infection, would together result in a cure for HIV. This premise is supported by observations in other viral systems where the relationship between productive infection, apoptosis resistance, and the development of latency or persistence has been established. Therefore we propose that research focused at understanding the mechanisms by which HIV induces apoptosis of infected cells, and ways that some cells escape the pro-apoptotic effects of productive HIV infection are critical to devising novel and rational approaches to cure HIV infection. Recent cases of successful control of human immunodeficiency virus (HIV) by bone marrow transplant in combination with suppressive antiretroviral therapy (ART) and very early initiation of ART have provided proof of concept that HIV infection might now be cured. Current efforts focusing on gene therapy, boosting HIV-specific immunity, reducing inflammation and activation of latency have all been the subject of recent excellent reviews. We now propose an additional avenue of research towards a cure for HIV: targeting HIV apoptosis regulatory pathways. The central enigma of HIV disease is that HIV infection kills most of the CD4 T cells that it infects, but those cells that are spared subsequently become a latent reservoir for HIV against which current medications are ineffective. We propose that if strategies could be devised which would favor the death of all cells which HIV infects, or if all latently infected cells that release HIV would succumb to viral-induced cytotoxicity, then these approaches combined with effective ART to prevent spreading infection, would together result in a cure for HIV. This premise is supported by observations in other viral systems where the relationship between productive infection, apoptosis resistance, and the development of latency or persistence has been established. Therefore we propose that research focused at understanding the mechanisms by which HIV induces apoptosis of infected cells, and ways that some cells escape the pro-apoptotic effects of productive HIV infection are critical to devising novel and rational approaches to cure HIV infection.Recent cases of successful control of human immunodeficiency virus (HIV) by bone marrow transplant in combination with suppressive antiretroviral therapy (ART) and very early initiation of ART have provided proof of concept that HIV infection might now be cured. Current efforts focusing on gene therapy, boosting HIV-specific immunity, reducing inflammation and activation of latency have all been the subject of recent excellent reviews. We now propose an additional avenue of research towards a cure for HIV: targeting HIV apoptosis regulatory pathways. The central enigma of HIV disease is that HIV infection kills most of the CD4 T cells that it infects, but those cells that are spared subsequently become a latent reservoir for HIV against which current medications are ineffective. We propose that if strategies could be devised which would favor the death of all cells which HIV infects, or if all latently infected cells that release HIV would succumb to viral-induced cytotoxicity, then these approaches combined with effective ART to prevent spreading infection, would together result in a cure for HIV. This premise is supported by observations in other viral systems where the relationship between productive infection, apoptosis resistance, and the development of latency or persistence has been established. Therefore we propose that research focused at understanding the mechanisms by which HIV induces apoptosis of infected cells, and ways that some cells escape the pro-apoptotic effects of productive HIV infection are critical to devising novel and rational approaches to cure HIV infection. |
Author | Badley, A D Lewin, S R Wightman, F Sainski, A |
Author_xml | – sequence: 1 givenname: A D surname: Badley fullname: Badley, A D email: badley.andrew@mayo.edu organization: Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Department of Molecular Medicine, Mayo Clinic – sequence: 2 givenname: A surname: Sainski fullname: Sainski, A organization: Department of Molecular Medicine, Mayo Clinic, Department of Molecular Pharmacology, Mayo Clinic – sequence: 3 givenname: F surname: Wightman fullname: Wightman, F organization: Department of Infectious Diseases, Alfred Hospital and Monash University, Centre for Biomedical Research, Burnet Institute – sequence: 4 givenname: S R surname: Lewin fullname: Lewin, S R organization: Department of Infectious Diseases, Alfred Hospital and Monash University, Centre for Biomedical Research, Burnet Institute |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23846220$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUc9rFDEYDVKxtfbqUQJevOz2y4-ZJBdhKWoLBS_qNWSSTDdlNhmTmUr_ezNuLWtRDPkF33sv78t7iY5iih6h1wTWBJg8t86FsqZA2Jpy-QydUOBkxaVURwf3Y3RWyi3UwRjQpn2BjimTvKUUTtBmM0w-h3iDrR8G7LyZtnis2w9zX7CpM2IzjjkZu8VTwnbOHl9efcMh9t5OIcVX6HlvhuLPHs5T9PXjhy8Xl6vrz5-uLjbXK9s0Ylq1pKdgOGWuZapVjveScyM74KKxjEjoVNe1TAgKnROiFsA75wUznTV1sVP0fq87zt3OO-vjlM2gxxx2Jt_rZIL-sxLDVt-kO80EA05JFXj3IJDT99mXSe9CWbo20ae5aCIUKE4a4P-HMqUU40Q0Ffr2CfQ2zTnWn6iCsqUglVrefnNo_tH17yAqYL0H2JxKyb5_hBDQS9j6V9h6CVvXsCuBPyHYMJklkNp8GP5NO9_Tyrik7vOB3b8zfgIiSbyp |
CitedBy_id | crossref_primary_10_1038_nm_4124 crossref_primary_10_3389_fmicb_2017_02007 crossref_primary_10_3389_fmicb_2019_02828 crossref_primary_10_3390_medicina55060297 crossref_primary_10_1016_j_omtn_2021_02_004 crossref_primary_10_1128_JVI_00012_17 crossref_primary_10_1016_j_crmeth_2021_100122 crossref_primary_10_1073_pnas_1818662116 crossref_primary_10_1111_voxs_12136 crossref_primary_10_1038_cddis_2013_473 crossref_primary_10_1097_QAD_0000000000003908 crossref_primary_10_1099_jgv_0_000402 crossref_primary_10_1172_JCI80564 crossref_primary_10_1089_aid_2018_0153 crossref_primary_10_1186_2052_8426_2_10 crossref_primary_10_3389_fimmu_2015_00506 crossref_primary_10_1186_s12977_018_0448_8 crossref_primary_10_1016_j_mayocp_2015_03_008 crossref_primary_10_3389_fmicb_2018_02022 crossref_primary_10_1097_COH_0000000000000279 crossref_primary_10_1089_aid_2019_0213 crossref_primary_10_3390_v6083181 crossref_primary_10_1007_s40265_015_0426_6 crossref_primary_10_1016_j_isci_2024_110324 crossref_primary_10_1016_j_immuni_2018_04_004 crossref_primary_10_3389_fimmu_2023_1096759 crossref_primary_10_1016_j_ijantimicag_2019_08_001 crossref_primary_10_1186_s12977_019_0494_x crossref_primary_10_1080_14786419_2019_1619720 crossref_primary_10_1155_2016_8910396 crossref_primary_10_1007_s11908_014_0392_2 crossref_primary_10_1128_JVI_02092_16 crossref_primary_10_1016_j_tim_2015_11_003 crossref_primary_10_1038_s41579_023_00914_1 crossref_primary_10_1172_JCI159569 crossref_primary_10_1038_s41586_022_04597_1 crossref_primary_10_1016_j_jinorgbio_2022_112117 crossref_primary_10_1186_s12977_015_0169_1 crossref_primary_10_1038_s41434_023_00413_1 crossref_primary_10_1016_j_bbrc_2015_02_102 crossref_primary_10_1128_JVI_03179_15 crossref_primary_10_1038_srep36111 crossref_primary_10_1038_s41598_020_60614_1 crossref_primary_10_1128_JVI_00231_16 crossref_primary_10_1038_s41598_017_12758_w crossref_primary_10_1080_15548627_2020_1831814 crossref_primary_10_1371_journal_ppat_1004071 crossref_primary_10_3390_molecules200814051 crossref_primary_10_1586_14787210_2014_956094 crossref_primary_10_1186_s12859_019_2990_3 crossref_primary_10_1371_journal_ppat_1004156 crossref_primary_10_3390_v6041837 |
Cites_doi | 10.4049/jimmunol.165.6.3293 10.1016/j.virol.2010.12.041 10.1126/science.3313729 10.1186/1743-422X-7-266 10.1186/1742-4690-6-52 10.1073/pnas.1002894107 10.2174/1570162033485203 10.1074/jbc.M112.408294 10.1186/1743-422X-8-554 10.1097/QAD.0b013e328330342c 10.1038/362359a0 10.1128/JVI.79.7.4510-4513.2005 10.1093/cid/cis383 10.1084/jem.187.3.403 10.1128/JVI.01350-09 10.1084/jem.182.4.1067 10.1016/j.coi.2009.02.009 10.1038/cddis.2010.77 10.1189/jlb.0312165 10.1126/science.1195271 10.1371/journal.pone.0006093 10.1056/NEJMoa0802905 10.1038/nature11286 10.1038/nrc2889 10.1182/blood-2010-09-309591 10.1016/S0092-8674(00)80110-5 10.1126/scitranslmed.3000931 10.1093/infdis/jis630 10.1371/journal.pone.0030176 10.1007/s00262-011-1008-4 10.1128/JVI.00793-12 10.2174/157016210793499312 10.1039/C1MB05386H 10.1016/j.bbrc.2011.09.007 10.1128/JVI.79.5.3139-3145.2005 10.1016/j.virol.2009.04.019 10.4049/jimmunol.1102483 10.1128/JVI.00249-06 10.1128/JVI.76.17.8776-8786.2002 10.1038/382722a0 10.1128/JVI.02033-10 10.1159/000100565 10.1182/blood-2007-06-097907 10.1128/JVI.78.11.6033-6042.2004 10.1517/14728214.2010.515210 10.1182/blood-2011-04-348540 10.1038/nbt1410 10.1038/mt.2011.310 10.1093/annonc/mdq009 10.1128/JVI.00161-10 10.1097/QAD.0b013e32835535f5 10.1371/journal.ppat.1000018 10.1038/sj.emboj.7600900 10.1089/aid.2008.0191 10.1038/nm0397-333 10.1016/j.febslet.2011.10.018 10.1097/QAI.0b013e3181d3dca3 10.1371/journal.ppat.1002288 10.1074/jbc.M110.180224 10.1097/QAD.0b013e328347bd77 10.1038/sj.emboj.7601074 10.1097/QAD.0b013e32832ec1dc 10.1038/ng2035 10.4049/jimmunol.175.3.1551 10.1016/j.vaccine.2011.09.118 10.1128/JVI.80.9.4570-4579.2006 10.1073/pnas.86.15.5974 10.1074/jbc.M111.274639 10.1186/1742-4690-8-80 10.1038/nri3262 10.1038/nature10660 10.4049/jimmunol.180.1.350 10.1371/journal.pone.0048340 10.1182/blood-2008-10-186601 10.1038/44755 10.1097/QAD.0b013e328333bfa1 10.1038/nri3173 10.1371/journal.pone.0048832 10.1016/j.chom.2008.06.008 10.1016/j.virol.2012.06.025 10.1371/journal.pbio.0030404 10.1146/annurev.immunol.18.1.665 10.1097/QAD.0b013e328340fe28 10.1186/1743-422X-9-149 10.1212/WNL.44.3_Part_1.481 10.1093/emboj/cdg188 10.1002/jcb.20532 10.1371/journal.pone.0002112 10.4049/jimmunol.171.3.1172 10.1172/JCI200522574 10.1038/8394 10.1038/387183a0 10.1016/j.immuni.2008.10.010 10.1074/jbc.M606324200 10.1128/JVI.02798-06 10.1016/j.cyto.2009.08.010 10.1158/1078-0432.CCR-08-0746 10.1371/journal.pmed.1000321 10.1038/sj.cdd.4400509 10.1038/385645a0 10.1128/JVI.02536-10 10.1073/pnas.84.9.2985 10.1074/jbc.M110.195537 10.4049/jimmunol.181.11.7713 10.1126/scitranslmed.3003761 10.1016/j.febslet.2011.03.017 10.1086/527324 10.2174/157488812800793108 10.1086/656721 10.4049/jimmunol.1100275 10.1371/journal.ppat.1003211 10.1016/j.immuni.2012.01.014 10.1038/34814 10.1097/QAI.0b013e3182895af4 10.1126/science.273.5283.1856 10.1016/j.ymthe.2005.07.524 10.1001/archinternmed.2012.2719 10.1038/333426a0 10.1615/CritRevImmunol.v32.i2.50 10.1186/1742-4690-5-19 10.1371/journal.ppat.1004071 10.1097/QAD.0b013e32835ecb8b 10.1186/1758-2652-13-S3-O15 10.1128/JVI.72.12.9698-9705.1998 10.1016/S0021-9258(19)75998-5 10.1016/j.ygeno.2012.11.008 |
ContentType | Journal Article |
Copyright | The Author(s) 2013 Copyright Nature Publishing Group Jul 2013 Copyright © 2013 Macmillan Publishers Limited 2013 Macmillan Publishers Limited |
Copyright_xml | – notice: The Author(s) 2013 – notice: Copyright Nature Publishing Group Jul 2013 – notice: Copyright © 2013 Macmillan Publishers Limited 2013 Macmillan Publishers Limited |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M2P M7P PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 7TO 7U9 H94 5PM |
DOI | 10.1038/cddis.2013.248 |
DatabaseName | SpringerOpen Free (Free internet resource, activated by CARLI) CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts Virology and AIDS Abstracts |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic CrossRef Oncogenes and Growth Factors Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Apoptosis modulation and HIV cure |
EISSN | 2041-4889 |
EndPage | e718 |
ExternalDocumentID | PMC3730421 4042531961 23846220 10_1038_cddis_2013_248 |
Genre | Review Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R56 AI095073 – fundername: NIAID NIH HHS grantid: U19 AI096109 – fundername: NIAID NIH HHS grantid: R01 AI110173 – fundername: NIAID NIH HHS grantid: 1R56AI095073-01A1 – fundername: NIGMS NIH HHS grantid: T32 GM072474 – fundername: NIAID NIH HHS grantid: R01 AI040384 |
GroupedDBID | --- 0R~ 3V. 53G 5VS 70F 7X7 88A 88I 8FE 8FH 8FI 8FJ AAJSJ ABAWZ ABUWG ACGFS ACSMW ADBBV ADRAZ AENEX AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CAG CCPQU COF DIK DWQXO E3Z EBLON EBS EJD EMOBN FRP FYUFA GNUQQ GROUPED_DOAJ HCIFZ HMCUK HYE HZ~ IPNFZ KQ8 LK8 M0L M2P M48 M7P M~E NAO O5R O5S O9- OK1 PIMPY PQQKQ PROAC RIG RNT RPM SNYQT TR2 UKHRP W2D AASML AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM PQGLB 7XB 8FK AARCD K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 7TO 7U9 H94 5PM |
ID | FETCH-LOGICAL-c557t-61f20a423d63969d4f844a8b0475c3180b9bb637720bd778b00edde73abcaabc3 |
IEDL.DBID | 7X7 |
ISSN | 2041-4889 |
IngestDate | Thu Aug 21 18:25:35 EDT 2025 Tue Aug 05 10:47:41 EDT 2025 Fri Jul 11 11:58:07 EDT 2025 Wed Aug 13 10:00:38 EDT 2025 Mon Jul 21 06:04:49 EDT 2025 Tue Jul 01 01:10:36 EDT 2025 Thu Apr 24 23:03:09 EDT 2025 Fri Feb 21 02:36:55 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Bcl2 apoptosis HIV cure Casp8p41 latency |
Language | English |
License | This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c557t-61f20a423d63969d4f844a8b0475c3180b9bb637720bd778b00edde73abcaabc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/1786208991?pq-origsite=%requestingapplication% |
PMID | 23846220 |
PQID | 1786208991 |
PQPubID | 2041963 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3730421 proquest_miscellaneous_1790941504 proquest_miscellaneous_1399934175 proquest_journals_1786208991 pubmed_primary_23846220 crossref_primary_10_1038_cddis_2013_248 crossref_citationtrail_10_1038_cddis_2013_248 springer_journals_10_1038_cddis_2013_248 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-07-01 |
PublicationDateYYYYMMDD | 2013-07-01 |
PublicationDate_xml | – month: 07 year: 2013 text: 2013-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Cell death & disease |
PublicationTitleAbbrev | Cell Death Dis |
PublicationTitleAlternate | Cell Death Dis |
PublicationYear | 2013 |
Publisher | Nature Publishing Group UK Springer Nature B.V Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Springer Nature B.V – name: Nature Publishing Group |
References | Stremlau, Perron, Welikala, Sodroski (CR72) 2005; 79 Hutter, Thiel (CR3) 2011; 25 Allers, Hutter, Hofmann, Loddenkemper, Rieger, Thiel (CR1) 2010; 117 Duh, Maury, Folks, Fauci, Rabson (CR35) 1989; 86 Sayers (CR107) 2011; 60 Scholler, Brady, Binder-Scholl, Hwang, Plesa, Hege (CR77) 2012; 4 Saleh, Wightman, Ramanayake, Alexander, Kumar, Khoury (CR130) 2011; 8 Migueles, Osborne, Royce, Compton, Joshi, Weeks (CR85) 2008; 29 Lodi, Meyer, Kelleher, Rosinska, Ghosn, Sannes (CR61) 2012; 172 Yuan, Wang, Crain, Fearns, Kim, Hua (CR70) 2012; 20 Chun, Davey, Engel, Lane, Fauci (CR91) 1999; 401 Gyrd-Hansen, Meier (CR103) 2010; 10 Lum, Badley (CR13) 2003; 1 Bren, Whitman, Cummins, Shepard, Rizza, Trushin (CR53) 2008; 3 Levy, Sereti, Tambussi, Routy, Lelievre, Delfraissy (CR94) 2012; 55 Reddy, Czuczman (CR104) 2010; 21 CR49 Dean, Carrington, Winkler, Huttley, Smith, Allikmets (CR80) 1996; 273 Lopez-Huertas, Mateos, Sanchez Del Cojo, Gomez-Esquer, Diaz-Gil, Rodriguez-Mora (CR15) 2013; 288 Saez-Cirion, Bacchus, Hocqueloux, Avettand-Fenoel, Girault, Lecuroux (CR60) 2013; 9 Perez, Wang, Miller, Jouvenot, Kim, Liu (CR69) 2008; 26 Chehimi, Papasavvas, Tomescu, Gekonge, Abdulhaqq, Raymond (CR19) 2010; 84 Sereti, Dunham, Spritzler, Aga, Proschan, Medvik (CR93) 2009; 113 Balazs, Chen, Hong, Rao, Yang, Baltimore (CR73) 2012; 481 Gandhi, Zheng, Bosch, Chan, Margolis, Read (CR89) 2010; 7 Klichko, Archin, Kaur, Lehrman, Margolis (CR132) 2006; 80 Dokmanovic, Marks (CR40) 2005; 96 Mita, Mita, Nawrocki, Giles (CR105) 2008; 14 Cho, Roche, Sandall, Brass, Seed, Xavier (CR7) 2012; 189 Zheng, Yang, Guocai, Pauza, Salvato (CR18) 2007; 50 Cummins, Badley (CR55) 2010; 1 Savarino, Mai, Norelli, El Daker, Valente, Rotili (CR118) 2009; 6 Hutter, Nowak, Mossner, Ganepola, Mussig, Allers (CR2) 2009; 360 Badley, Parato, Cameron, Kravcik, Phenix, Ashby (CR14) 1999; 6 Wightman, Solomon, Khoury, Green, Gray, Gorry (CR26) 2010; 202 Lai (CR71) 2012; 7 Tornatore, Chandra, Berger, Major (CR28) 1994; 44 Chinnaiyan, Woffendin, Dixit, Nabel (CR50) 1997; 3 Archin, Liberty, Kashuba, Choudhary, Kuruc, Crooks (CR63) 2012; 487 Shehu-Xhilaga, Rhodes, Wightman, Liu, Solomon, Saleh (CR66) 2009; 23 Pallikkuth, Rogers, Villinger, Dosterii, Vaccari, Franchini (CR99) 2011; 29 Archin, Keedy, Espeseth, Dang, Hazuda, Margolis (CR120) 2009; 23 CR137 CR138 Strauss, Knape, Melzner, Debatin (CR109) 2003; 171 Guidi, Puglia, Gabbiani, Landini, Gamberi, Fregona (CR114) 2012; 8 Levy, Lacabaratz, Weiss, Viard, Goujard, Lelievre (CR92) 2009; 119 Kutsch, Benveniste, Shaw, Levy (CR38) 2002; 76 Banerjee, Archin, Michaels, Belkina, Denis, Bradner (CR135) 2012; 92 Han, Li, Chen, Wang, Mei, Wu (CR10) 2012; 7 Schnepple, Shepard, Bren, Cummins, Natesampillai, Trushin (CR20) 2011; 286 Nie, Bren, Vlahakis, Schimnich, Brenchley, Trushin (CR108) 2007; 81 Loetscher, Uguccioni, Bordoli, Baggiolini, Moser, Chizzolini (CR57) 1998; 391 Unsoeld, Pircher (CR56) 2005; 79 CR65 CR64 CR62 Martin, Qi, Gao, Yamada, Martin, Pereyra (CR84) 2007; 39 Chun, Carruth, Finzi, Shen, DiGiuseppe, Taylor (CR39) 1997; 387 Lam, Yeung, Chan (CR9) 2011; 8 Lewis, DaFonseca, Chomont, Palamara, Tardugno, Mai (CR115) 2011; 25 Ying, Zhang, Zhou, Qu, Wang, Liu (CR125) 2012; 7 Azmi, Wang, Philip, Mohammad, Sarkar (CR102) 2011; 16 Jordan, Bisgrove, Verdin (CR37) 2003; 22 Lopez-Huertas, Mateos, Sanchez Del Cojo, Gomez-Esquer, Diaz-Gil, Rodriguez-Mora (CR21) 2013; 288 Taiwo, Hunt, Gandhi, Ellingson, McKenna, Jacobson (CR88) 2013; 63 Pallikkuth, Parmigiani, Pahwa (CR98) 2012; 32 Treand, du Chene, Bres, Kiernan, Benarous, Benkirane (CR32) 2006; 25 Shan, Yang, Rabi, Bravo, Shroff, Irizarry (CR41) 2011; 85 Archin, Espeseth, Parker, Cheema, Hazuda, Margolis (CR48) 2009; 25 Xing, Bullen, Shroff, Shan, Yang, Manucci (CR134) 2011; 85 Mukherjee, Majumdar, Vipat, Mishra, Chakrabarti (CR8) 2012; 9 Cameron, Saleh, Sallmann, Solomon, Wightman, Evans (CR45) 2010; 107 Montefiori, Mitchell (CR113) 1987; 84 Brentjens, Riviere, Park, Davila, Wang, Stefanski (CR76) 2011; 118 DiGiusto, Krishnan, Li, Li, Li, Rao (CR79) 2010; 2 Bernhard, Barreto, Saunders, Dahabieh, Johnson, Sadowski (CR128) 2011; 585 Galluzzi, Brenner, Morselli, Touat, Kroemer (CR11) 2008; 4 Sadelain, Brentjens, Riviere (CR75) 2009; 21 Lum, Schnepple, Nie, Sanchez-Dardon, Mbisa, Mihowich (CR96) 2004; 78 Liu, Paxton, Choe, Ceradini, Martin, Horuk (CR81) 1996; 86 Shan, Deng, Shroff, Durand, Rabi, Yang (CR67) 2012; 36 Mueller, Do, Altork, Artlett, Gracely, Katsetos (CR97) 2008; 180 Bouchat, Gatot, Kabeya, Cardona, Colin, Herbein (CR127) 2012; 26 Pereyra, Jia, McLaren, Telenti, de Bakker, Walker (CR83) 2010; 330 CR6 Altmann, Hammerschmidt (CR12) 2005; 3 Marini, Harper, Romerio (CR42) 2008; 181 Bosque, Famiglietti, Weyrich, Goulston, Planelles (CR68) 2011; 7 CR86 CR124 Fernandez, Zeichner (CR126) 2010; 7 Reuse, Calao, Kabeya, Guiguen, Gatot, Quivy (CR117) 2009; 4 Saleh, Solomon, Wightman, Xhilaga, Cameron, Lewin (CR46) 2007; 110 Conti, Matarrese, Varano, Gauzzi, Sato, Malorni (CR100) 2000; 165 Caron, Duluc, Fremaux, Jeannin, David, Gascan (CR111) 2005; 175 Hatano, Jain, Hunt, Lee, Sinclair, Do (CR87) 2012; 208 Burnett, Lim, Calafi, Rossi, Schaffer, Arkin (CR43) 2010; 84 Thibault, Imbeault, Tardif, Tremblay (CR112) 2009; 389 CR129 Aillet, Masutani, Elbim, Raoul, Chene, Nugeyre (CR51) 1998; 72 Rasmussen, Schmeltz Sogaard, Brinkmann, Wightman, Lewin, Melchjorsen (CR123) 2013; 9 Deeks, Autran, Berkhout, Benkirane, Cairns, Chomont (CR30) 2012; 12 Choi, Lee, Oh, Hyun, Ro, Kim (CR119) 2010; 24 Samson, Libert, Doranz, Rucker, Liesnard, Farber (CR82) 1996; 382 Weis, Brown, Cusack, Paulson, Skehel, Wiley (CR5) 1988; 333 Zaunders, Ip, Munier, Kaufmann, Suzuki, Brereton (CR58) 2006; 80 Perez, de Vinuesa, Sanchez-Duffhues, Marquez, Bellido, Munoz-Fernandez (CR131) 2010; 8 Chun, Nickle, Justement, Meyers, Roby, Hallahan (CR24) 2008; 197 Lassen, Hebbeler, Bhattacharyya, Lobritz, Greene (CR44) 2012; 7 Veselinovic, Neff, Mulder, Akkina (CR74) 2012; 432 Berro, de la Fuente, Klase, Kehn, Parvin, Pumfery (CR17) 2007; 282 Finzi, Blankson, Siliciano, Margolick, Chadwick, Pierson (CR22) 1999; 5 Embretson, Zupancic, Ribas, Burke, Racz, Tenner-Racz (CR25) 1993; 362 Matalon, Palmer, Nold, Furlan, Kassu, Fossati (CR121) 2010; 54 He, Chen, Farzan, Choe, Ohagen, Gartner (CR29) 1997; 385 Conti, Rainaldi, Matarrese, Varano, Rivabene, Columba (CR16) 1998; 187 Folks, Justement, Kinter, Dinarello, Fauci (CR36) 1987; 238 Pierson, McArthur, Siliciano (CR23) 2000; 18 CR90 Spiegel, Herbst, Niedobitek, Foss, Stein (CR27) 1992; 140 Shishido, Wolschendorf, Duverger, Wagner, Kappes, Jones (CR133) 2012; 86 Suzuki, Nagao, Kato, Matsumoto, Nerome, Nakajima (CR4) 1986; 261 Seder, Grabstein, Berzofsky, McDyer (CR95) 1995; 182 Li, Kim, Li, Zaia, Yee, Anderson (CR78) 2005; 12 Kim, Cheng, Lindsley, Yang, Cheng (CR106) 2005; 6 Wang, Xu, Sullivan, Souder, Argyris, Acheampong (CR136) 2005; 115 Han, Lin, An, Xu, Yang, O’Connell (CR33) 2008; 4 Weng, Araki, Subedi (CR54) 2012; 12 Williams, Chen, Kwon, Ruiz-Jarabo, Verdin, Greene (CR31) 2006; 25 Fernandez Larrosa, Croci, Riva, Bibini, Luzzi, Saracco (CR101) 2008; 5 Micheva-Viteva, Kobayashi, Edelstein, Pacchia, Lee, Graci (CR139) 2011; 286 Yang, Xing, Shan, O’Connell, Dinoso, Shen (CR47) 2009; 119 Pace, Agosto, Graf, O’Doherty (CR34) 2011; 411 Huber, Doyon, Plaks, Fyne, Mellors, Sluis-Cremer (CR116) 2011; 286 Wang, Ragupathy, Zhao, Hewlett (CR52) 2011; 414 Victoriano, Imai, Togami, Ueno, Asamitsu, Suzuki (CR122) 2011; 585 Trushin, Carena, Bren, Rizza, Dong, Abraham (CR59) 2012; 189 Li, Jiang, Tapping (CR110) 2010; 49 C Tornatore (BFcddis2013248_CR28) 1994; 44 S Matalon (BFcddis2013248_CR121) 2010; 54 NW Cummins (BFcddis2013248_CR55) 2010; 1 L Zheng (BFcddis2013248_CR18) 2007; 50 S Saleh (BFcddis2013248_CR46) 2007; 110 A Savarino (BFcddis2013248_CR118) 2009; 6 L Galluzzi (BFcddis2013248_CR11) 2008; 4 MJ Pace (BFcddis2013248_CR34) 2011; 411 A Bosque (BFcddis2013248_CR68) 2011; 7 A Saez-Cirion (BFcddis2013248_CR60) 2013; 9 BFcddis2013248_CR64 BFcddis2013248_CR62 KG Lassen (BFcddis2013248_CR44) 2012; 7 S Micheva-Viteva (BFcddis2013248_CR139) 2011; 286 D Finzi (BFcddis2013248_CR22) 1999; 5 DC Montefiori (BFcddis2013248_CR113) 1987; 84 NM Archin (BFcddis2013248_CR120) 2009; 23 EE Perez (BFcddis2013248_CR69) 2008; 26 BS Choi (BFcddis2013248_CR119) 2010; 24 H Hatano (BFcddis2013248_CR87) 2012; 208 S Pallikkuth (BFcddis2013248_CR99) 2011; 29 JJ Zaunders (BFcddis2013248_CR58) 2006; 80 AF Victoriano (BFcddis2013248_CR122) 2011; 585 V Klichko (BFcddis2013248_CR132) 2006; 80 NM Archin (BFcddis2013248_CR48) 2009; 25 EJ Duh (BFcddis2013248_CR35) 1989; 86 GD Bren (BFcddis2013248_CR53) 2008; 3 F Wightman (BFcddis2013248_CR26) 2010; 202 J He (BFcddis2013248_CR29) 1997; 385 MR Lopez-Huertas (BFcddis2013248_CR15) 2013; 288 MG Lewis (BFcddis2013248_CR115) 2011; 25 PU Cameron (BFcddis2013248_CR45) 2010; 107 RA Seder (BFcddis2013248_CR95) 1995; 182 F Aillet (BFcddis2013248_CR51) 1998; 72 RJ Brentjens (BFcddis2013248_CR76) 2011; 118 Y Levy (BFcddis2013248_CR92) 2009; 119 BFcddis2013248_CR49 HC Yang (BFcddis2013248_CR47) 2009; 119 SG Deeks (BFcddis2013248_CR30) 2012; 12 J Scholler (BFcddis2013248_CR77) 2012; 4 L Shan (BFcddis2013248_CR67) 2012; 36 Y Han (BFcddis2013248_CR33) 2008; 4 M Dokmanovic (BFcddis2013248_CR40) 2005; 96 S Reuse (BFcddis2013248_CR117) 2009; 4 JJ Lum (BFcddis2013248_CR13) 2003; 1 TW Chun (BFcddis2013248_CR39) 1997; 387 J Chehimi (BFcddis2013248_CR19) 2010; 84 R Liu (BFcddis2013248_CR81) 1996; 86 RT Gandhi (BFcddis2013248_CR89) 2010; 7 J Yuan (BFcddis2013248_CR70) 2012; 20 G Caron (BFcddis2013248_CR111) 2005; 175 M Dean (BFcddis2013248_CR80) 1996; 273 G Fernandez (BFcddis2013248_CR126) 2010; 7 Y Lai (BFcddis2013248_CR71) 2012; 7 TJ Sayers (BFcddis2013248_CR107) 2011; 60 AM Chinnaiyan (BFcddis2013248_CR50) 1997; 3 BFcddis2013248_CR137 J Embretson (BFcddis2013248_CR25) 1993; 362 TM Folks (BFcddis2013248_CR36) 1987; 238 BFcddis2013248_CR138 M Gyrd-Hansen (BFcddis2013248_CR103) 2010; 10 BFcddis2013248_CR6 TW Chun (BFcddis2013248_CR91) 1999; 401 A Marini (BFcddis2013248_CR42) 2008; 181 JL Cho (BFcddis2013248_CR7) 2012; 189 S Xing (BFcddis2013248_CR134) 2011; 85 NM Archin (BFcddis2013248_CR63) 2012; 487 K Huber (BFcddis2013248_CR116) 2011; 286 WY Lam (BFcddis2013248_CR9) 2011; 8 I Sereti (BFcddis2013248_CR93) 2009; 113 G Hutter (BFcddis2013248_CR3) 2011; 25 DJ Schnepple (BFcddis2013248_CR20) 2011; 286 G Strauss (BFcddis2013248_CR109) 2003; 171 AB Balazs (BFcddis2013248_CR73) 2012; 481 M Sadelain (BFcddis2013248_CR75) 2009; 21 DL DiGiusto (BFcddis2013248_CR79) 2010; 2 H Spiegel (BFcddis2013248_CR27) 1992; 140 BFcddis2013248_CR124 BFcddis2013248_CR129 C Banerjee (BFcddis2013248_CR135) 2012; 92 F Pereyra (BFcddis2013248_CR83) 2010; 330 TW Chun (BFcddis2013248_CR24) 2008; 197 T Shishido (BFcddis2013248_CR133) 2012; 86 W Weis (BFcddis2013248_CR5) 1988; 333 SA Williams (BFcddis2013248_CR31) 2006; 25 S Lodi (BFcddis2013248_CR61) 2012; 172 JJ Lum (BFcddis2013248_CR96) 2004; 78 M Veselinovic (BFcddis2013248_CR74) 2012; 432 D Kim (BFcddis2013248_CR106) 2005; 6 AD Badley (BFcddis2013248_CR14) 1999; 6 T Pierson (BFcddis2013248_CR23) 2000; 18 W Bernhard (BFcddis2013248_CR128) 2011; 585 S Saleh (BFcddis2013248_CR130) 2011; 8 L Conti (BFcddis2013248_CR16) 1998; 187 O Kutsch (BFcddis2013248_CR38) 2002; 76 S Mukherjee (BFcddis2013248_CR8) 2012; 9 BFcddis2013248_CR90 N Reddy (BFcddis2013248_CR104) 2010; 21 X Wang (BFcddis2013248_CR52) 2011; 414 Y Levy (BFcddis2013248_CR94) 2012; 55 A Jordan (BFcddis2013248_CR37) 2003; 22 AS Azmi (BFcddis2013248_CR102) 2011; 16 YM Mueller (BFcddis2013248_CR97) 2008; 180 L Shan (BFcddis2013248_CR41) 2011; 85 X Li (BFcddis2013248_CR110) 2010; 49 SA Trushin (BFcddis2013248_CR59) 2012; 189 FX Wang (BFcddis2013248_CR136) 2005; 115 M Samson (BFcddis2013248_CR82) 1996; 382 M Perez (BFcddis2013248_CR131) 2010; 8 S Pallikkuth (BFcddis2013248_CR98) 2012; 32 AC Mita (BFcddis2013248_CR105) 2008; 14 JC Burnett (BFcddis2013248_CR43) 2010; 84 PN Fernandez Larrosa (BFcddis2013248_CR101) 2008; 5 BFcddis2013248_CR86 MR Lopez-Huertas (BFcddis2013248_CR21) 2013; 288 B Taiwo (BFcddis2013248_CR88) 2013; 63 TA Rasmussen (BFcddis2013248_CR123) 2013; 9 M Altmann (BFcddis2013248_CR12) 2005; 3 SA Migueles (BFcddis2013248_CR85) 2008; 29 F Guidi (BFcddis2013248_CR114) 2012; 8 G Hutter (BFcddis2013248_CR2) 2009; 360 K Allers (BFcddis2013248_CR1) 2010; 117 S Thibault (BFcddis2013248_CR112) 2009; 389 M Stremlau (BFcddis2013248_CR72) 2005; 79 NP Weng (BFcddis2013248_CR54) 2012; 12 L Conti (BFcddis2013248_CR100) 2000; 165 MJ Li (BFcddis2013248_CR78) 2005; 12 R Berro (BFcddis2013248_CR17) 2007; 282 H Ying (BFcddis2013248_CR125) 2012; 7 M Shehu-Xhilaga (BFcddis2013248_CR66) 2009; 23 BFcddis2013248_CR65 Y Suzuki (BFcddis2013248_CR4) 1986; 261 P Loetscher (BFcddis2013248_CR57) 1998; 391 MP Martin (BFcddis2013248_CR84) 2007; 39 X Han (BFcddis2013248_CR10) 2012; 7 H Unsoeld (BFcddis2013248_CR56) 2005; 79 C Treand (BFcddis2013248_CR32) 2006; 25 S Bouchat (BFcddis2013248_CR127) 2012; 26 Z Nie (BFcddis2013248_CR108) 2007; 81 15046251 - Curr HIV Res. 2003 Jul;1(3):261-74 23089590 - J Infect Dis. 2013 Jul;208(1):50-6 16277553 - PLoS Biol. 2005 Dec;3(12):e404 19775907 - Cytokine. 2010 Jan;49(1):1-9 21992606 - Retrovirology. 2011;8:80 19327974 - Curr Opin Immunol. 2009 Apr;21(2):215-23 19564922 - PLoS One. 2009;4(6):e6093 16034093 - J Immunol. 2005 Aug 1;175(3):1551-7 22553251 - Sci Transl Med. 2012 May 2;4(132):132ra53 21051598 - Science. 2010 Dec 10;330(6010):1551-7 23324661 - AIDS. 2013 May 15;27(8):1199-208 20979453 - J Infect Dis. 2010 Dec 1;202(11):1738-48 19017960 - J Immunol. 2008 Dec 1;181(11):7713-20 9811703 - J Virol. 1998 Dec;72(12):9698-705 21998586 - PLoS Pathog. 2011 Oct;7(10):e1002288 22486585 - Curr Stem Cell Res Ther. 2012 Jul;7(4):310-7 23166597 - PLoS One. 2012;7(11):e48832 8751444 - Nature. 1996 Aug 22;382(6593):722-5 18097036 - J Immunol. 2008 Jan 1;180(1):350-60 23216614 - Crit Rev Immunol. 2012;32(2):173-95 15709033 - J Virol. 2005 Mar;79(5):3139-45 20133382 - Ann Oncol. 2010 Sep;21(9):1756-64 9450746 - Nature. 1998 Jan 22;391(6665):344-5 3374584 - Nature. 1988 Jun 2;333(6172):426-31 22273578 - Mol Ther. 2012 Apr;20(4):849-59 9449720 - J Exp Med. 1998 Feb 2;187(3):403-13 21173593 - AIDS. 2011 Jan 14;25(2):273-4 16370391 - Curr Opin Investig Drugs. 2005 Dec;6(12):1250-8 23139776 - PLoS One. 2012;7(11):e48340 21859711 - J Biol Chem. 2011 Oct 14;286(41):35742-54 20042498 - J Virol. 2010 Mar;84(6):2762-73 21148083 - Blood. 2011 Mar 10;117(10):2791-9 20651737 - Nat Rev Cancer. 2010 Aug;10(8):561-74 23392463 - J Acquir Immune Defic Syndr. 2013 May 1;63(1):101-4 17005693 - J Virol. 2006 Oct;80(20):10162-72 15141001 - J Virol. 2004 Jun;78(11):6033-42 3782153 - J Biol Chem. 1986 Dec 25;261(36):17057-61 16319923 - EMBO J. 2006 Jan 11;25(1):139-49 22406268 - Immunity. 2012 Mar 23;36(3):491-501 20711481 - PLoS Med. 2010;7(8). pii: e1000321. doi: 10.1371/journal.pmed.1000321 18587387 - Nat Biotechnol. 2008 Jul;26(7):808-16 21498519 - J Biol Chem. 2011 Jun 17;286(24):21083-91 17496894 - Nat Genet. 2007 Jun;39(6):733-40 9024664 - Nature. 1997 Feb 13;385(6617):645-9 19590405 - AIDS. 2009 Sep 10;23(14):1799-806 20154582 - AIDS. 2010 Feb 20;24(4):609-11 1530997 - Am J Pathol. 1992 Jan;140(1):15-22 22134777 - Mol Biosyst. 2012 Apr;8(4):985-93 9144289 - Nature. 1997 May 8;387(6629):183-8 8791590 - Science. 1996 Sep 27;273(5283):1856-62 15767451 - J Virol. 2005 Apr;79(7):4510-3 21284992 - Virology. 2011 Mar 15;411(2):344-54 18260759 - J Infect Dis. 2008 Mar 1;197(5):714-20 19062316 - Immunity. 2008 Dec 19;29(6):1009-21 22550117 - Clin Infect Dis. 2012 Jul;55(2):291-300 21368875 - Cell Death Dis. 2010;1:e99 16611917 - J Virol. 2006 May;80(9):4570-9 18516228 - PLoS Pathog. 2008 May;4(5):e1000018 20812891 - Expert Opin Emerg Drugs. 2011 Mar;16(1):59-70 10553903 - Nature. 1999 Oct 28;401(6756):874-5 21531716 - J Biol Chem. 2011 Jun 24;286(25):22211-8 20300007 - J Acquir Immune Defic Syndr. 2010 May 1;54(1):1-9 9055863 - Nat Med. 1997 Mar;3(3):333-7 23370291 - Hum Vaccin Immunother. 2013 May;9(5):993-1001 21996099 - Vaccine. 2011 Nov 15;29(49):9229-38 10229227 - Nat Med. 1999 May;5(5):512-7 22555163 - AIDS. 2012 Jul 31;26(12):1473-82 19213682 - N Engl J Med. 2009 Feb 12;360(7):692-8 18261236 - Retrovirology. 2008;5:19 16088937 - J Cell Biochem. 2005 Oct 1;96(2):293-304 18461165 - PLoS One. 2008;3(5):e2112 23516360 - PLoS Pathog. 2013 Mar;9(3):e1003211 10837072 - Annu Rev Immunol. 2000;18:665-708 3313729 - Science. 1987 Nov 6;238(4828):800-2 19486542 - Retrovirology. 2009;6:52 16115802 - Mol Ther. 2005 Nov;12(5):900-9 21626033 - Cancer Immunol Immunother. 2011 Aug;60(8):1173-80 22139420 - Nature. 2012 Jan 5;481(7379):81-4 19239360 - AIDS Res Hum Retroviruses. 2009 Feb;25(2):207-12 17356300 - Intervirology. 2007;50(3):224-8 20555022 - Sci Transl Med. 2010 Jun 16;2(36):36ra43 20636281 - Curr HIV Res. 2010 Sep;8(6):418-29 19380868 - Blood. 2009 Jun 18;113(25):6304-14 8096068 - Nature. 1993 Mar 25;362(6418):359-62 15630452 - J Clin Invest. 2005 Jan;115(1):128-37 18698017 - Clin Cancer Res. 2008 Aug 15;14(16):5000-5 19609198 - AIDS. 2009 Sep 24;23(15):2047-50 12682019 - EMBO J. 2003 Apr 15;22(8):1868-77 2762307 - Proc Natl Acad Sci U S A. 1989 Aug;86(15):5974-8 19287090 - J Clin Invest. 2009 Apr;119(4):997-1007 12874203 - J Immunol. 2003 Aug 1;171(3):1172-82 22866982 - Virol J. 2012;9:149 19805909 - J Clin Invest. 2009 Nov;119(11):3473-86 22802411 - J Immunol. 2012 Aug 15;189(4):1835-42 17442709 - J Virol. 2007 Jul;81(13):6947-56 22696646 - J Virol. 2012 Sep;86(17):9055-69 22875804 - J Immunol. 2012 Sep 15;189(6):2879-89 21402072 - FEBS Lett. 2011 Apr 6;585(7):1103-11 16601680 - EMBO J. 2006 Apr 19;25(8):1690-9 12163598 - J Virol. 2002 Sep;76(17):8776-86 8145919 - Neurology. 1994 Mar;44(3 Pt 1):481-7 20942961 - Virol J. 2010;7:266 22832125 - Virology. 2012 Oct 25;432(2):505-10 23364796 - J Biol Chem. 2013 Mar 15;288(11):7626-44 10975846 - J Immunol. 2000 Sep 15;165(6):3293-300 22291913 - PLoS One. 2012;7(1):e30176 22421787 - Nat Rev Immunol. 2012 Apr;12(4):306-15 22826124 - Arch Intern Med. 2012 Sep 10;172(16):1252-5 22020221 - FEBS Lett. 2011 Nov 16;585(22):3549-54 19447460 - Virology. 2009 Jun 20;389(1-2):20-5 21945613 - Biochem Biophys Res Commun. 2011 Oct 14;414(1):20-4 8756719 - Cell. 1996 Aug 9;86(3):367-77 17881634 - Blood. 2007 Dec 15;110(13):4161-4 20837531 - Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16934-9 18692773 - Cell Host Microbe. 2008 Aug 14;4(2):134-46 22814509 - Nat Rev Immunol. 2012 Aug;12(8):607-14 3106982 - Proc Natl Acad Sci U S A. 1987 May;84(9):2985-9 17237230 - J Biol Chem. 2007 Mar 16;282(11):8207-18 7561680 - J Exp Med. 1995 Oct 1;182(4):1067-77 20357084 - J Virol. 2010 Jun;84(12):5958-74 21505294 - AIDS. 2011 Jul 17;25(11):1347-56 22837004 - Nature. 2012 Jul 26;487(7408):482-5 23195410 - Genomics. 2013 Feb;101(2):101-12 10381636 - Cell Death Differ. 1999 May;6(5):420-32 21430059 - J Virol. 2011 Jun;85(11):5384-93 21849486 - Blood. 2011 Nov 3;118(18):4817-28 22802445 - J Leukoc Biol. 2012 Dec;92(6):1147-54 22185562 - Virol J. 2011;8:554 21471244 - J Virol. 2011 Jun;85(12):6060-4 |
References_xml | – volume: 165 start-page: 3293 year: 2000 end-page: 3300 ident: CR100 article-title: Dual role of the HIV-1 vpr protein in the modulation of the apoptotic response of T cells publication-title: J Immunol doi: 10.4049/jimmunol.165.6.3293 – volume: 411 start-page: 344 year: 2011 end-page: 354 ident: CR34 article-title: HIV reservoirs and latency models publication-title: Virology doi: 10.1016/j.virol.2010.12.041 – ident: CR138 – volume: 238 start-page: 800 year: 1987 end-page: 802 ident: CR36 article-title: Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line publication-title: Science doi: 10.1126/science.3313729 – volume: 7 start-page: 266 year: 2010 ident: CR126 article-title: Cell line-dependent variability in HIV activation employing DNMT inhibitors publication-title: Virol J doi: 10.1186/1743-422X-7-266 – volume: 6 start-page: 52 year: 2009 ident: CR118 article-title: "Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence publication-title: Retrovirology doi: 10.1186/1742-4690-6-52 – volume: 107 start-page: 16934 year: 2010 end-page: 16939 ident: CR45 article-title: Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1002894107 – volume: 1 start-page: 261 year: 2003 end-page: 274 ident: CR13 article-title: Resistance to apoptosis: mechanism for the development of HIV reservoirs publication-title: Curr HIV Res doi: 10.2174/1570162033485203 – volume: 288 start-page: 7626 year: 2013 end-page: 7644 ident: CR15 article-title: The presence of HIV-1 Tat second exon delays Fas-mediated apoptosis in CD4+ T lymphocytes: a potential mechanism for persistent viral production publication-title: J Biol Chem doi: 10.1074/jbc.M112.408294 – volume: 8 start-page: 554 year: 2011 ident: CR9 article-title: Apoptosis, cytokine and chemokine induction by non-structural 1 (NS1) proteins encoded by different influenza subtypes publication-title: Virol J doi: 10.1186/1743-422X-8-554 – ident: CR129 – volume: 23 start-page: 2047 year: 2009 end-page: 2050 ident: CR66 article-title: The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells publication-title: AIDS doi: 10.1097/QAD.0b013e328330342c – volume: 362 start-page: 359 year: 1993 end-page: 362 ident: CR25 article-title: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS publication-title: Nature doi: 10.1038/362359a0 – volume: 79 start-page: 4510 year: 2005 end-page: 4513 ident: CR56 article-title: Complex memory T-cell phenotypes revealed by coexpression of CD62L and CCR7 publication-title: J Virol doi: 10.1128/JVI.79.7.4510-4513.2005 – volume: 119 start-page: 997 year: 2009 end-page: 1007 ident: CR92 article-title: Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment publication-title: J Clin Invest – volume: 55 start-page: 291 year: 2012 end-page: 300 ident: CR94 article-title: Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study publication-title: Clin Infect Dis doi: 10.1093/cid/cis383 – volume: 187 start-page: 403 year: 1998 end-page: 413 ident: CR16 article-title: The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS publication-title: J Exp Med doi: 10.1084/jem.187.3.403 – volume: 84 start-page: 2762 year: 2010 end-page: 2773 ident: CR19 article-title: Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand publication-title: J Virol doi: 10.1128/JVI.01350-09 – volume: 182 start-page: 1067 year: 1995 end-page: 1077 ident: CR95 article-title: Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15 publication-title: J Exp Med doi: 10.1084/jem.182.4.1067 – volume: 21 start-page: 215 year: 2009 end-page: 223 ident: CR75 article-title: The promise and potential pitfalls of chimeric antigen receptors publication-title: Curr Opin Immunol doi: 10.1016/j.coi.2009.02.009 – volume: 1 start-page: e99 year: 2010 ident: CR55 article-title: Mechanisms of HIV-associated lymphocyte apoptosis: 2010 publication-title: Cell Death Dis doi: 10.1038/cddis.2010.77 – volume: 92 start-page: 1147 year: 2012 end-page: 1154 ident: CR135 article-title: BET bromodomain inhibition as a novel strategy for reactivation of HIV-1 publication-title: J Leukoc Biol doi: 10.1189/jlb.0312165 – volume: 330 start-page: 1551 year: 2010 end-page: 1557 ident: CR83 article-title: The major genetic determinants of HIV-1 control affect HLA class I peptide presentation publication-title: Science doi: 10.1126/science.1195271 – volume: 6 start-page: 1250 year: 2005 end-page: 1258 ident: CR106 article-title: Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer publication-title: Curr Opin Investig Drugs – volume: 4 start-page: e6093 year: 2009 ident: CR117 article-title: Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection publication-title: PLoS One doi: 10.1371/journal.pone.0006093 – volume: 360 start-page: 692 year: 2009 end-page: 698 ident: CR2 article-title: Long-term control of HIV by CCR5 Δ32/Δ32 stem-cell transplantation publication-title: N Engl J Med doi: 10.1056/NEJMoa0802905 – volume: 487 start-page: 482 year: 2012 end-page: 485 ident: CR63 article-title: Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy publication-title: Nature doi: 10.1038/nature11286 – volume: 10 start-page: 561 year: 2010 end-page: 574 ident: CR103 article-title: IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer publication-title: Nat Rev Cancer doi: 10.1038/nrc2889 – volume: 117 start-page: 2791 year: 2010 end-page: 2799 ident: CR1 article-title: Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation publication-title: Blood doi: 10.1182/blood-2010-09-309591 – volume: 86 start-page: 367 year: 1996 end-page: 377 ident: CR81 article-title: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection publication-title: Cell doi: 10.1016/S0092-8674(00)80110-5 – volume: 2 start-page: 36ra43 year: 2010 ident: CR79 article-title: RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma publication-title: Sci Transl Med doi: 10.1126/scitranslmed.3000931 – volume: 208 start-page: 50 year: 2012 end-page: 56 ident: CR87 article-title: Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells publication-title: J Infect Dis doi: 10.1093/infdis/jis630 – volume: 7 start-page: e30176 year: 2012 ident: CR44 article-title: A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs publication-title: PLoS One doi: 10.1371/journal.pone.0030176 – volume: 60 start-page: 1173 year: 2011 end-page: 1180 ident: CR107 article-title: Targeting the extrinsic apoptosis signaling pathway for cancer therapy publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-011-1008-4 – volume: 86 start-page: 9055 year: 2012 end-page: 9069 ident: CR133 article-title: Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation publication-title: J Virol doi: 10.1128/JVI.00793-12 – volume: 8 start-page: 418 year: 2010 end-page: 429 ident: CR131 article-title: Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency publication-title: Curr HIV Res doi: 10.2174/157016210793499312 – volume: 8 start-page: 985 year: 2012 end-page: 993 ident: CR114 article-title: 2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds publication-title: Mol Biosyst doi: 10.1039/C1MB05386H – volume: 414 start-page: 20 year: 2011 end-page: 24 ident: CR52 article-title: Molecules from apoptotic pathways modulate HIV-1 replication in Jurkat cells publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2011.09.007 – volume: 79 start-page: 3139 year: 2005 end-page: 3145 ident: CR72 article-title: Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction publication-title: J Virol doi: 10.1128/JVI.79.5.3139-3145.2005 – ident: CR137 – volume: 389 start-page: 20 year: 2009 end-page: 25 ident: CR112 article-title: TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+ T cells publication-title: Virology doi: 10.1016/j.virol.2009.04.019 – ident: CR6 – volume: 189 start-page: 2879 year: 2012 end-page: 2889 ident: CR7 article-title: Enhanced Tim3 activity improves survival after influenza infection publication-title: J Immunol doi: 10.4049/jimmunol.1102483 – volume: 72 start-page: 9698 year: 1998 end-page: 9705 ident: CR51 article-title: Human immunodeficiency virus induces a dual regulation of Bcl-2, resulting in persistent infection of CD4(+) T- or monocytic cell lines publication-title: J Virol – volume: 80 start-page: 10162 year: 2006 end-page: 10172 ident: CR58 article-title: Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection publication-title: J Virol doi: 10.1128/JVI.00249-06 – volume: 76 start-page: 8776 year: 2002 end-page: 8786 ident: CR38 article-title: Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency publication-title: J Virol doi: 10.1128/JVI.76.17.8776-8786.2002 – volume: 382 start-page: 722 year: 1996 end-page: 725 ident: CR82 article-title: Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene publication-title: Nature doi: 10.1038/382722a0 – ident: CR86 – volume: 85 start-page: 6060 year: 2011 end-page: 6064 ident: CR134 article-title: Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation publication-title: J Virol doi: 10.1128/JVI.02033-10 – volume: 50 start-page: 224 year: 2007 end-page: 228 ident: CR18 article-title: HIV Tat protein increases Bcl-2 expression in monocytes which inhibits monocyte apoptosis induced by tumor necrosis factor-alpha-related apoptosis-induced ligand publication-title: Intervirology doi: 10.1159/000100565 – volume: 110 start-page: 4161 year: 2007 end-page: 4164 ident: CR46 article-title: CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency publication-title: Blood doi: 10.1182/blood-2007-06-097907 – volume: 78 start-page: 6033 year: 2004 end-page: 6042 ident: CR96 article-title: Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity publication-title: J Virol doi: 10.1128/JVI.78.11.6033-6042.2004 – volume: 16 start-page: 59 year: 2011 end-page: 70 ident: CR102 article-title: Emerging Bcl-2 inhibitors for the treatment of cancer publication-title: Expert Opin Emerg Drugs doi: 10.1517/14728214.2010.515210 – volume: 9 start-page: 5 year: 2013 ident: CR123 article-title: Comparison of HDAC inhibitors in clinical development: Effect on HIV production in latently infected cells and T-cell activation publication-title: Hum Vaccin Immunother – volume: 118 start-page: 4817 year: 2011 end-page: 4828 ident: CR76 article-title: Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias publication-title: Blood doi: 10.1182/blood-2011-04-348540 – volume: 26 start-page: 808 year: 2008 end-page: 816 ident: CR69 article-title: Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases publication-title: Nat Biotechnol doi: 10.1038/nbt1410 – volume: 20 start-page: 849 year: 2012 end-page: 859 ident: CR70 article-title: Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T cell resistance and enrichment publication-title: Mol Ther doi: 10.1038/mt.2011.310 – volume: 21 start-page: 1756 year: 2010 end-page: 1764 ident: CR104 article-title: Enhancing activity and overcoming chemoresistance in hematologic malignancies with bortezomib: preclinical mechanistic studies publication-title: Ann Oncol doi: 10.1093/annonc/mdq009 – volume: 84 start-page: 5958 year: 2010 end-page: 5974 ident: CR43 article-title: Combinatorial latency reactivation for HIV-1 subtypes and variants publication-title: J Virol doi: 10.1128/JVI.00161-10 – volume: 26 start-page: 1473 year: 2012 end-page: 1482 ident: CR127 article-title: Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1+ HAART-treated patients publication-title: AIDS doi: 10.1097/QAD.0b013e32835535f5 – volume: 4 start-page: e1000018 year: 2008 ident: CR11 article-title: Viral control of mitochondrial apoptosis publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1000018 – volume: 25 start-page: 139 year: 2006 end-page: 149 ident: CR31 article-title: NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation publication-title: EMBO J doi: 10.1038/sj.emboj.7600900 – volume: 25 start-page: 207 year: 2009 end-page: 212 ident: CR48 article-title: Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid publication-title: AIDS Res Hum Retroviruses doi: 10.1089/aid.2008.0191 – volume: 3 start-page: 333 year: 1997 end-page: 337 ident: CR50 article-title: The inhibition of pro-apoptotic ICE-like proteases enhances HIV replication publication-title: Nat Med doi: 10.1038/nm0397-333 – volume: 585 start-page: 3549 year: 2011 end-page: 3554 ident: CR128 article-title: The Suv39H1 methyltransferase inhibitor chaetocin causes induction of integrated HIV-1 without producing a T cell response publication-title: FEBS Lett doi: 10.1016/j.febslet.2011.10.018 – volume: 54 start-page: 1 year: 2010 end-page: 9 ident: CR121 article-title: The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression on CD4(+) T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e3181d3dca3 – volume: 7 start-page: e1002288 year: 2011 ident: CR68 article-title: Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1002288 – volume: 286 start-page: 22211 year: 2011 end-page: 22218 ident: CR116 article-title: Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells publication-title: J Biol Chem doi: 10.1074/jbc.M110.180224 – volume: 25 start-page: 1347 year: 2011 end-page: 1356 ident: CR115 article-title: Gold drug auranofin restricts the viral reservoir in the monkey AIDS model and induces containment of viral load following ART suspension publication-title: AIDS doi: 10.1097/QAD.0b013e328347bd77 – volume: 25 start-page: 1690 year: 2006 end-page: 1699 ident: CR32 article-title: Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter publication-title: EMBO J doi: 10.1038/sj.emboj.7601074 – volume: 23 start-page: 1799 year: 2009 end-page: 1806 ident: CR120 article-title: Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors publication-title: AIDS doi: 10.1097/QAD.0b013e32832ec1dc – ident: CR49 – volume: 39 start-page: 733 year: 2007 end-page: 740 ident: CR84 article-title: Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1 publication-title: Nat Genet doi: 10.1038/ng2035 – volume: 175 start-page: 1551 year: 2005 end-page: 1557 ident: CR111 article-title: Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells publication-title: J Immunol doi: 10.4049/jimmunol.175.3.1551 – volume: 29 start-page: 9229 year: 2011 end-page: 9238 ident: CR99 article-title: Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replication publication-title: Vaccine doi: 10.1016/j.vaccine.2011.09.118 – volume: 80 start-page: 4570 year: 2006 end-page: 4579 ident: CR132 article-title: Hexamethylbisacetamide remodels the human immunodeficiency virus type 1 (HIV-1) promoter and induces Tat-independent HIV-1 expression but blunts cell activation publication-title: J Virol doi: 10.1128/JVI.80.9.4570-4579.2006 – volume: 86 start-page: 5974 year: 1989 end-page: 5978 ident: CR35 article-title: Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.86.15.5974 – volume: 286 start-page: 35742 year: 2011 end-page: 35754 ident: CR20 article-title: Isolation of a TRAIL antagonist from the serum of HIV-infected patients publication-title: J Biol Chem doi: 10.1074/jbc.M111.274639 – volume: 8 start-page: 80 year: 2011 ident: CR130 article-title: Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells publication-title: Retrovirology doi: 10.1186/1742-4690-8-80 – volume: 12 start-page: 607 year: 2012 end-page: 614 ident: CR30 article-title: Towards an HIV cure: a global scientific strategy publication-title: Nat Rev Immunol doi: 10.1038/nri3262 – volume: 481 start-page: 81 year: 2012 end-page: 84 ident: CR73 article-title: Antibody-based protection against HIV infection by vectored immunoprophylaxis publication-title: Nature doi: 10.1038/nature10660 – volume: 180 start-page: 350 year: 2008 end-page: 360 ident: CR97 article-title: IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses publication-title: J Immunol doi: 10.4049/jimmunol.180.1.350 – volume: 7 start-page: e48340 year: 2012 ident: CR10 article-title: Influenza virus A/Beijing/501/2009(H1N1) NS1 interacts with beta-tubulin and induces disruption of the microtubule network and apoptosis on A549 cells publication-title: PLoS One doi: 10.1371/journal.pone.0048340 – volume: 113 start-page: 6304 year: 2009 end-page: 6314 ident: CR93 article-title: IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection publication-title: Blood doi: 10.1182/blood-2008-10-186601 – volume: 401 start-page: 874 year: 1999 end-page: 875 ident: CR91 article-title: Re-emergence of HIV after stopping therapy publication-title: Nature doi: 10.1038/44755 – volume: 24 start-page: 609 year: 2010 end-page: 611 ident: CR119 article-title: Novel histone deacetylase inhibitors CG05 and CG06 effectively reactivate latently infected HIV-1 publication-title: AIDS doi: 10.1097/QAD.0b013e328333bfa1 – volume: 12 start-page: 306 year: 2012 end-page: 315 ident: CR54 article-title: The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation publication-title: Nat Rev Immunol doi: 10.1038/nri3173 – volume: 7 start-page: e48832 year: 2012 ident: CR125 article-title: Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB publication-title: PLoS One doi: 10.1371/journal.pone.0048832 – volume: 4 start-page: 134 year: 2008 end-page: 146 ident: CR33 article-title: Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough publication-title: Cell Host Microbe doi: 10.1016/j.chom.2008.06.008 – volume: 432 start-page: 505 year: 2012 end-page: 510 ident: CR74 article-title: Topical gel formulation of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 confers protection against HIV-1 vaginal challenge in a humanized mouse model publication-title: Virology doi: 10.1016/j.virol.2012.06.025 – volume: 3 start-page: e404 year: 2005 ident: CR12 article-title: Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis publication-title: PLoS Biol doi: 10.1371/journal.pbio.0030404 – volume: 18 start-page: 665 year: 2000 end-page: 708 ident: CR23 article-title: Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.18.1.665 – volume: 25 start-page: 273 year: 2011 end-page: 274 ident: CR3 article-title: Allogeneic transplantation of CCR5-deficient progenitor cells in a patient with HIV infection: an update after 3 years and the search for patient no. 2 publication-title: AIDS doi: 10.1097/QAD.0b013e328340fe28 – volume: 9 start-page: 149 year: 2012 ident: CR8 article-title: Non structural protein of avian influenza A (H11N1) virus is a weaker suppressor of immune responses but capable of inducing apoptosis in host cells publication-title: Virol J doi: 10.1186/1743-422X-9-149 – volume: 44 start-page: 481 issue: 3 Pt 1 year: 1994 end-page: 487 ident: CR28 article-title: HIV-1 infection of subcortical astrocytes in the pediatric central nervous system publication-title: Neurology doi: 10.1212/WNL.44.3_Part_1.481 – volume: 119 start-page: 3473 year: 2009 end-page: 3486 ident: CR47 article-title: Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation publication-title: J Clin Invest – volume: 261 start-page: 17057 year: 1986 end-page: 17061 ident: CR4 article-title: Human influenza A virus hemagglutinin distinguishes sialyloligosaccharides in membrane-associated gangliosides as its receptor which mediates the adsorption and fusion processes of virus infection. Specificity for oligosaccharides and sialic acids and the sequence to which sialic acid is attached publication-title: J Biol Chem – volume: 288 start-page: 7626 year: 2013 end-page: 7644 ident: CR21 article-title: The presence of HIV-1 Tat protein second exon delays Fas protein-mediated apoptosis in CD4+ T lymphocytes: a potential mechanism for persistent viral production publication-title: J Biol Chem doi: 10.1074/jbc.M112.408294 – volume: 22 start-page: 1868 year: 2003 end-page: 1877 ident: CR37 article-title: HIV reproducibly establishes a latent infection after acute infection of T cells in vitro publication-title: EMBO J doi: 10.1093/emboj/cdg188 – volume: 96 start-page: 293 year: 2005 end-page: 304 ident: CR40 article-title: Prospects: histone deacetylase inhibitors publication-title: J Cell Biochem doi: 10.1002/jcb.20532 – volume: 3 start-page: e2112 year: 2008 ident: CR53 article-title: Infected cell killing by HIV-1 protease promotes NF-kappaB dependent HIV-1 replication publication-title: PLoS One doi: 10.1371/journal.pone.0002112 – volume: 140 start-page: 15 year: 1992 end-page: 22 ident: CR27 article-title: Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells publication-title: Am J Pathol – volume: 171 start-page: 1172 year: 2003 end-page: 1182 ident: CR109 article-title: Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells publication-title: J Immunol doi: 10.4049/jimmunol.171.3.1172 – volume: 115 start-page: 128 year: 2005 end-page: 137 ident: CR136 article-title: IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART publication-title: J Clin Invest doi: 10.1172/JCI200522574 – volume: 5 start-page: 512 year: 1999 end-page: 517 ident: CR22 article-title: Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy publication-title: Nat Med doi: 10.1038/8394 – volume: 387 start-page: 183 year: 1997 end-page: 188 ident: CR39 article-title: Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection publication-title: Nature doi: 10.1038/387183a0 – volume: 29 start-page: 1009 year: 2008 end-page: 1021 ident: CR85 article-title: Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control publication-title: Immunity doi: 10.1016/j.immuni.2008.10.010 – volume: 282 start-page: 8207 year: 2007 end-page: 8218 ident: CR17 article-title: Identifying the membrane proteome of HIV-1 latently infected cells publication-title: J Biol Chem doi: 10.1074/jbc.M606324200 – volume: 81 start-page: 6947 year: 2007 end-page: 6956 ident: CR108 article-title: Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo publication-title: J Virol doi: 10.1128/JVI.02798-06 – volume: 49 start-page: 1 year: 2010 end-page: 9 ident: CR110 article-title: Toll-like receptor signaling in cell proliferation and survival publication-title: Cytokine doi: 10.1016/j.cyto.2009.08.010 – ident: CR64 – volume: 14 start-page: 5000 year: 2008 end-page: 5005 ident: CR105 article-title: Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-08-0746 – volume: 7 start-page: e1000321 year: 2010 ident: CR89 article-title: The effect of Raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial publication-title: PLoS Med doi: 10.1371/journal.pmed.1000321 – volume: 6 start-page: 420 year: 1999 end-page: 432 ident: CR14 article-title: Dynamic correlation of apoptosis and immune activation during treatment of HIV infection publication-title: Cell Death Differ doi: 10.1038/sj.cdd.4400509 – volume: 385 start-page: 645 year: 1997 end-page: 649 ident: CR29 article-title: CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia publication-title: Nature doi: 10.1038/385645a0 – volume: 85 start-page: 5384 year: 2011 end-page: 5393 ident: CR41 article-title: Influence of host gene transcription level and orientation on HIV-1 latency in a primary-cell model publication-title: J Virol doi: 10.1128/JVI.02536-10 – volume: 84 start-page: 2985 year: 1987 end-page: 2989 ident: CR113 article-title: Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.84.9.2985 – volume: 286 start-page: 21083 year: 2011 end-page: 21091 ident: CR139 article-title: High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitor publication-title: J Biol Chem doi: 10.1074/jbc.M110.195537 – volume: 181 start-page: 7713 year: 2008 end-page: 7720 ident: CR42 article-title: An in vitro system to model the establishment and reactivation of HIV-1 latency publication-title: J Immunol doi: 10.4049/jimmunol.181.11.7713 – volume: 4 start-page: 132ra53 year: 2012 ident: CR77 article-title: Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells publication-title: Sci Transl Med doi: 10.1126/scitranslmed.3003761 – volume: 585 start-page: 1103 year: 2011 end-page: 1111 ident: CR122 article-title: Novel histone deacetylase inhibitor NCH-51 activates latent HIV-1 gene expression publication-title: FEBS Lett doi: 10.1016/j.febslet.2011.03.017 – volume: 197 start-page: 714 year: 2008 end-page: 720 ident: CR24 article-title: Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy publication-title: J Infect Dis doi: 10.1086/527324 – volume: 7 start-page: 310 year: 2012 end-page: 317 ident: CR71 article-title: CCR5-targeted hematopoietic stem cell gene approaches for HIV disease: current progress and future prospects publication-title: Curr Stem Cell Res Ther doi: 10.2174/157488812800793108 – volume: 202 start-page: 1738 year: 2010 end-page: 1748 ident: CR26 article-title: Both CD31(+) and CD31(−) naive CD4(+) T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapy publication-title: J Infect Dis doi: 10.1086/656721 – ident: CR124 – volume: 189 start-page: 1835 year: 2012 end-page: 1842 ident: CR59 article-title: SDF-1alpha degrades whereas glycoprotein 120 upregulates Bcl-2 interacting mediator of death extralong isoform: implications for the development of T cell memory publication-title: J Immunol doi: 10.4049/jimmunol.1100275 – volume: 9 start-page: e1003211 year: 2013 ident: CR60 article-title: Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1003211 – volume: 36 start-page: 491 year: 2012 end-page: 501 ident: CR67 article-title: Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation publication-title: Immunity doi: 10.1016/j.immuni.2012.01.014 – volume: 391 start-page: 344 year: 1998 end-page: 345 ident: CR57 article-title: CCR5 is characteristic of Th1 lymphocytes publication-title: Nature doi: 10.1038/34814 – ident: CR65 – ident: CR90 – volume: 63 start-page: 101 year: 2013 end-page: 104 ident: CR88 article-title: CD8+ T-cell activation in HIV-1-infected patients experiencing transient low-level viremia during antiretroviral therapy publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e3182895af4 – volume: 273 start-page: 1856 year: 1996 end-page: 1862 ident: CR80 article-title: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study publication-title: Science doi: 10.1126/science.273.5283.1856 – volume: 12 start-page: 900 year: 2005 end-page: 909 ident: CR78 article-title: Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy publication-title: Mol Ther doi: 10.1016/j.ymthe.2005.07.524 – volume: 172 start-page: 1252 year: 2012 end-page: 1255 ident: CR61 article-title: Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion publication-title: Arch Intern Med doi: 10.1001/archinternmed.2012.2719 – volume: 333 start-page: 426 year: 1988 end-page: 431 ident: CR5 article-title: Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid publication-title: Nature doi: 10.1038/333426a0 – ident: CR62 – volume: 32 start-page: 173 year: 2012 end-page: 195 ident: CR98 article-title: Role of IL-21 and IL-21 receptor on B cells in HIV infection publication-title: Crit Rev Immunol doi: 10.1615/CritRevImmunol.v32.i2.50 – volume: 5 start-page: 19 year: 2008 ident: CR101 article-title: Apoptosis resistance in HIV-1 persistently-infected cells is independent of active viral replication and involves modulation of the apoptotic mitochondrial pathway publication-title: Retrovirology doi: 10.1186/1742-4690-5-19 – volume: 487 start-page: 482 year: 2012 ident: BFcddis2013248_CR63 publication-title: Nature doi: 10.1038/nature11286 – volume: 110 start-page: 4161 year: 2007 ident: BFcddis2013248_CR46 publication-title: Blood doi: 10.1182/blood-2007-06-097907 – volume: 3 start-page: 333 year: 1997 ident: BFcddis2013248_CR50 publication-title: Nat Med doi: 10.1038/nm0397-333 – volume: 118 start-page: 4817 year: 2011 ident: BFcddis2013248_CR76 publication-title: Blood doi: 10.1182/blood-2011-04-348540 – volume: 282 start-page: 8207 year: 2007 ident: BFcddis2013248_CR17 publication-title: J Biol Chem doi: 10.1074/jbc.M606324200 – volume: 3 start-page: e404 year: 2005 ident: BFcddis2013248_CR12 publication-title: PLoS Biol doi: 10.1371/journal.pbio.0030404 – volume: 22 start-page: 1868 year: 2003 ident: BFcddis2013248_CR37 publication-title: EMBO J doi: 10.1093/emboj/cdg188 – volume: 6 start-page: 52 year: 2009 ident: BFcddis2013248_CR118 publication-title: Retrovirology doi: 10.1186/1742-4690-6-52 – volume: 197 start-page: 714 year: 2008 ident: BFcddis2013248_CR24 publication-title: J Infect Dis doi: 10.1086/527324 – volume: 238 start-page: 800 year: 1987 ident: BFcddis2013248_CR36 publication-title: Science doi: 10.1126/science.3313729 – volume: 202 start-page: 1738 year: 2010 ident: BFcddis2013248_CR26 publication-title: J Infect Dis doi: 10.1086/656721 – volume: 26 start-page: 1473 year: 2012 ident: BFcddis2013248_CR127 publication-title: AIDS doi: 10.1097/QAD.0b013e32835535f5 – volume: 4 start-page: e1000018 year: 2008 ident: BFcddis2013248_CR11 publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1000018 – volume: 7 start-page: e1002288 year: 2011 ident: BFcddis2013248_CR68 publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1002288 – ident: BFcddis2013248_CR64 – volume: 180 start-page: 350 year: 2008 ident: BFcddis2013248_CR97 publication-title: J Immunol doi: 10.4049/jimmunol.180.1.350 – volume: 10 start-page: 561 year: 2010 ident: BFcddis2013248_CR103 publication-title: Nat Rev Cancer doi: 10.1038/nrc2889 – volume: 14 start-page: 5000 year: 2008 ident: BFcddis2013248_CR105 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-08-0746 – volume: 29 start-page: 1009 year: 2008 ident: BFcddis2013248_CR85 publication-title: Immunity doi: 10.1016/j.immuni.2008.10.010 – volume: 25 start-page: 1690 year: 2006 ident: BFcddis2013248_CR32 publication-title: EMBO J doi: 10.1038/sj.emboj.7601074 – volume: 481 start-page: 81 year: 2012 ident: BFcddis2013248_CR73 publication-title: Nature doi: 10.1038/nature10660 – volume: 25 start-page: 273 year: 2011 ident: BFcddis2013248_CR3 publication-title: AIDS doi: 10.1097/QAD.0b013e328340fe28 – volume: 117 start-page: 2791 year: 2010 ident: BFcddis2013248_CR1 publication-title: Blood doi: 10.1182/blood-2010-09-309591 – ident: BFcddis2013248_CR129 doi: 10.1371/journal.ppat.1004071 – volume: 119 start-page: 997 year: 2009 ident: BFcddis2013248_CR92 publication-title: J Clin Invest – volume: 50 start-page: 224 year: 2007 ident: BFcddis2013248_CR18 publication-title: Intervirology doi: 10.1159/000100565 – volume: 54 start-page: 1 year: 2010 ident: BFcddis2013248_CR121 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e3181d3dca3 – volume: 165 start-page: 3293 year: 2000 ident: BFcddis2013248_CR100 publication-title: J Immunol doi: 10.4049/jimmunol.165.6.3293 – volume: 12 start-page: 306 year: 2012 ident: BFcddis2013248_CR54 publication-title: Nat Rev Immunol doi: 10.1038/nri3173 – volume: 288 start-page: 7626 year: 2013 ident: BFcddis2013248_CR15 publication-title: J Biol Chem doi: 10.1074/jbc.M112.408294 – volume: 79 start-page: 4510 year: 2005 ident: BFcddis2013248_CR56 publication-title: J Virol doi: 10.1128/JVI.79.7.4510-4513.2005 – volume: 115 start-page: 128 year: 2005 ident: BFcddis2013248_CR136 publication-title: J Clin Invest doi: 10.1172/JCI200522574 – volume: 86 start-page: 5974 year: 1989 ident: BFcddis2013248_CR35 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.86.15.5974 – volume: 81 start-page: 6947 year: 2007 ident: BFcddis2013248_CR108 publication-title: J Virol doi: 10.1128/JVI.02798-06 – volume: 286 start-page: 22211 year: 2011 ident: BFcddis2013248_CR116 publication-title: J Biol Chem doi: 10.1074/jbc.M110.180224 – volume: 60 start-page: 1173 year: 2011 ident: BFcddis2013248_CR107 publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-011-1008-4 – volume: 8 start-page: 554 year: 2011 ident: BFcddis2013248_CR9 publication-title: Virol J doi: 10.1186/1743-422X-8-554 – volume: 585 start-page: 3549 year: 2011 ident: BFcddis2013248_CR128 publication-title: FEBS Lett doi: 10.1016/j.febslet.2011.10.018 – volume: 63 start-page: 101 year: 2013 ident: BFcddis2013248_CR88 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e3182895af4 – volume: 7 start-page: e30176 year: 2012 ident: BFcddis2013248_CR44 publication-title: PLoS One doi: 10.1371/journal.pone.0030176 – volume: 29 start-page: 9229 year: 2011 ident: BFcddis2013248_CR99 publication-title: Vaccine doi: 10.1016/j.vaccine.2011.09.118 – volume: 8 start-page: 80 year: 2011 ident: BFcddis2013248_CR130 publication-title: Retrovirology doi: 10.1186/1742-4690-8-80 – volume: 273 start-page: 1856 year: 1996 ident: BFcddis2013248_CR80 publication-title: Science doi: 10.1126/science.273.5283.1856 – volume: 32 start-page: 173 year: 2012 ident: BFcddis2013248_CR98 publication-title: Crit Rev Immunol doi: 10.1615/CritRevImmunol.v32.i2.50 – volume: 39 start-page: 733 year: 2007 ident: BFcddis2013248_CR84 publication-title: Nat Genet doi: 10.1038/ng2035 – ident: BFcddis2013248_CR137 – ident: BFcddis2013248_CR65 – volume: 414 start-page: 20 year: 2011 ident: BFcddis2013248_CR52 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2011.09.007 – volume: 76 start-page: 8776 year: 2002 ident: BFcddis2013248_CR38 publication-title: J Virol doi: 10.1128/JVI.76.17.8776-8786.2002 – volume: 9 start-page: 5 year: 2013 ident: BFcddis2013248_CR123 publication-title: Hum Vaccin Immunother – ident: BFcddis2013248_CR86 doi: 10.1097/QAD.0b013e32835ecb8b – volume: 92 start-page: 1147 year: 2012 ident: BFcddis2013248_CR135 publication-title: J Leukoc Biol doi: 10.1189/jlb.0312165 – volume: 1 start-page: 261 year: 2003 ident: BFcddis2013248_CR13 publication-title: Curr HIV Res doi: 10.2174/1570162033485203 – volume: 140 start-page: 15 year: 1992 ident: BFcddis2013248_CR27 publication-title: Am J Pathol – ident: BFcddis2013248_CR138 doi: 10.1186/1758-2652-13-S3-O15 – volume: 72 start-page: 9698 year: 1998 ident: BFcddis2013248_CR51 publication-title: J Virol doi: 10.1128/JVI.72.12.9698-9705.1998 – volume: 8 start-page: 985 year: 2012 ident: BFcddis2013248_CR114 publication-title: Mol Biosyst doi: 10.1039/C1MB05386H – volume: 36 start-page: 491 year: 2012 ident: BFcddis2013248_CR67 publication-title: Immunity doi: 10.1016/j.immuni.2012.01.014 – volume: 20 start-page: 849 year: 2012 ident: BFcddis2013248_CR70 publication-title: Mol Ther doi: 10.1038/mt.2011.310 – volume: 4 start-page: 134 year: 2008 ident: BFcddis2013248_CR33 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2008.06.008 – volume: 333 start-page: 426 year: 1988 ident: BFcddis2013248_CR5 publication-title: Nature doi: 10.1038/333426a0 – volume: 7 start-page: e48832 year: 2012 ident: BFcddis2013248_CR125 publication-title: PLoS One doi: 10.1371/journal.pone.0048832 – ident: BFcddis2013248_CR62 – volume: 5 start-page: 19 year: 2008 ident: BFcddis2013248_CR101 publication-title: Retrovirology doi: 10.1186/1742-4690-5-19 – volume: 181 start-page: 7713 year: 2008 ident: BFcddis2013248_CR42 publication-title: J Immunol doi: 10.4049/jimmunol.181.11.7713 – volume: 189 start-page: 1835 year: 2012 ident: BFcddis2013248_CR59 publication-title: J Immunol doi: 10.4049/jimmunol.1100275 – volume: 23 start-page: 2047 year: 2009 ident: BFcddis2013248_CR66 publication-title: AIDS doi: 10.1097/QAD.0b013e328330342c – volume: 286 start-page: 35742 year: 2011 ident: BFcddis2013248_CR20 publication-title: J Biol Chem doi: 10.1074/jbc.M111.274639 – ident: BFcddis2013248_CR90 – volume: 12 start-page: 607 year: 2012 ident: BFcddis2013248_CR30 publication-title: Nat Rev Immunol doi: 10.1038/nri3262 – volume: 7 start-page: e48340 year: 2012 ident: BFcddis2013248_CR10 publication-title: PLoS One doi: 10.1371/journal.pone.0048340 – volume: 16 start-page: 59 year: 2011 ident: BFcddis2013248_CR102 publication-title: Expert Opin Emerg Drugs doi: 10.1517/14728214.2010.515210 – volume: 25 start-page: 1347 year: 2011 ident: BFcddis2013248_CR115 publication-title: AIDS doi: 10.1097/QAD.0b013e328347bd77 – volume: 6 start-page: 420 year: 1999 ident: BFcddis2013248_CR14 publication-title: Cell Death Differ doi: 10.1038/sj.cdd.4400509 – volume: 411 start-page: 344 year: 2011 ident: BFcddis2013248_CR34 publication-title: Virology doi: 10.1016/j.virol.2010.12.041 – volume: 172 start-page: 1252 year: 2012 ident: BFcddis2013248_CR61 publication-title: Arch Intern Med doi: 10.1001/archinternmed.2012.2719 – volume: 5 start-page: 512 year: 1999 ident: BFcddis2013248_CR22 publication-title: Nat Med doi: 10.1038/8394 – volume: 25 start-page: 139 year: 2006 ident: BFcddis2013248_CR31 publication-title: EMBO J doi: 10.1038/sj.emboj.7600900 – volume: 182 start-page: 1067 year: 1995 ident: BFcddis2013248_CR95 publication-title: J Exp Med doi: 10.1084/jem.182.4.1067 – volume: 360 start-page: 692 year: 2009 ident: BFcddis2013248_CR2 publication-title: N Engl J Med doi: 10.1056/NEJMoa0802905 – volume: 432 start-page: 505 year: 2012 ident: BFcddis2013248_CR74 publication-title: Virology doi: 10.1016/j.virol.2012.06.025 – volume: 7 start-page: 310 year: 2012 ident: BFcddis2013248_CR71 publication-title: Curr Stem Cell Res Ther doi: 10.2174/157488812800793108 – volume: 119 start-page: 3473 year: 2009 ident: BFcddis2013248_CR47 publication-title: J Clin Invest – volume: 12 start-page: 900 year: 2005 ident: BFcddis2013248_CR78 publication-title: Mol Ther doi: 10.1016/j.ymthe.2005.07.524 – volume: 6 start-page: 1250 year: 2005 ident: BFcddis2013248_CR106 publication-title: Curr Opin Investig Drugs – volume: 288 start-page: 7626 year: 2013 ident: BFcddis2013248_CR21 publication-title: J Biol Chem doi: 10.1074/jbc.M112.408294 – volume: 44 start-page: 481 issue: 3 Pt 1 year: 1994 ident: BFcddis2013248_CR28 publication-title: Neurology doi: 10.1212/WNL.44.3_Part_1.481 – volume: 86 start-page: 367 year: 1996 ident: BFcddis2013248_CR81 publication-title: Cell doi: 10.1016/S0092-8674(00)80110-5 – volume: 401 start-page: 874 year: 1999 ident: BFcddis2013248_CR91 publication-title: Nature doi: 10.1038/44755 – volume: 21 start-page: 1756 year: 2010 ident: BFcddis2013248_CR104 publication-title: Ann Oncol doi: 10.1093/annonc/mdq009 – volume: 391 start-page: 344 year: 1998 ident: BFcddis2013248_CR57 publication-title: Nature doi: 10.1038/34814 – volume: 382 start-page: 722 year: 1996 ident: BFcddis2013248_CR82 publication-title: Nature doi: 10.1038/382722a0 – volume: 49 start-page: 1 year: 2010 ident: BFcddis2013248_CR110 publication-title: Cytokine doi: 10.1016/j.cyto.2009.08.010 – volume: 585 start-page: 1103 year: 2011 ident: BFcddis2013248_CR122 publication-title: FEBS Lett doi: 10.1016/j.febslet.2011.03.017 – volume: 387 start-page: 183 year: 1997 ident: BFcddis2013248_CR39 publication-title: Nature doi: 10.1038/387183a0 – volume: 2 start-page: 36ra43 year: 2010 ident: BFcddis2013248_CR79 publication-title: Sci Transl Med doi: 10.1126/scitranslmed.3000931 – volume: 80 start-page: 4570 year: 2006 ident: BFcddis2013248_CR132 publication-title: J Virol doi: 10.1128/JVI.80.9.4570-4579.2006 – volume: 385 start-page: 645 year: 1997 ident: BFcddis2013248_CR29 publication-title: Nature doi: 10.1038/385645a0 – volume: 330 start-page: 1551 year: 2010 ident: BFcddis2013248_CR83 publication-title: Science doi: 10.1126/science.1195271 – volume: 261 start-page: 17057 year: 1986 ident: BFcddis2013248_CR4 publication-title: J Biol Chem doi: 10.1016/S0021-9258(19)75998-5 – volume: 189 start-page: 2879 year: 2012 ident: BFcddis2013248_CR7 publication-title: J Immunol doi: 10.4049/jimmunol.1102483 – volume: 26 start-page: 808 year: 2008 ident: BFcddis2013248_CR69 publication-title: Nat Biotechnol doi: 10.1038/nbt1410 – volume: 24 start-page: 609 year: 2010 ident: BFcddis2013248_CR119 publication-title: AIDS doi: 10.1097/QAD.0b013e328333bfa1 – volume: 18 start-page: 665 year: 2000 ident: BFcddis2013248_CR23 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.18.1.665 – volume: 362 start-page: 359 year: 1993 ident: BFcddis2013248_CR25 publication-title: Nature doi: 10.1038/362359a0 – volume: 389 start-page: 20 year: 2009 ident: BFcddis2013248_CR112 publication-title: Virology doi: 10.1016/j.virol.2009.04.019 – volume: 4 start-page: 132ra53 year: 2012 ident: BFcddis2013248_CR77 publication-title: Sci Transl Med doi: 10.1126/scitranslmed.3003761 – volume: 25 start-page: 207 year: 2009 ident: BFcddis2013248_CR48 publication-title: AIDS Res Hum Retroviruses doi: 10.1089/aid.2008.0191 – volume: 107 start-page: 16934 year: 2010 ident: BFcddis2013248_CR45 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1002894107 – volume: 3 start-page: e2112 year: 2008 ident: BFcddis2013248_CR53 publication-title: PLoS One doi: 10.1371/journal.pone.0002112 – volume: 23 start-page: 1799 year: 2009 ident: BFcddis2013248_CR120 publication-title: AIDS doi: 10.1097/QAD.0b013e32832ec1dc – volume: 187 start-page: 403 year: 1998 ident: BFcddis2013248_CR16 publication-title: J Exp Med doi: 10.1084/jem.187.3.403 – volume: 85 start-page: 5384 year: 2011 ident: BFcddis2013248_CR41 publication-title: J Virol doi: 10.1128/JVI.02536-10 – volume: 21 start-page: 215 year: 2009 ident: BFcddis2013248_CR75 publication-title: Curr Opin Immunol doi: 10.1016/j.coi.2009.02.009 – volume: 113 start-page: 6304 year: 2009 ident: BFcddis2013248_CR93 publication-title: Blood doi: 10.1182/blood-2008-10-186601 – ident: BFcddis2013248_CR6 doi: 10.1016/j.ygeno.2012.11.008 – volume: 7 start-page: 266 year: 2010 ident: BFcddis2013248_CR126 publication-title: Virol J doi: 10.1186/1743-422X-7-266 – volume: 85 start-page: 6060 year: 2011 ident: BFcddis2013248_CR134 publication-title: J Virol doi: 10.1128/JVI.02033-10 – volume: 79 start-page: 3139 year: 2005 ident: BFcddis2013248_CR72 publication-title: J Virol doi: 10.1128/JVI.79.5.3139-3145.2005 – volume: 175 start-page: 1551 year: 2005 ident: BFcddis2013248_CR111 publication-title: J Immunol doi: 10.4049/jimmunol.175.3.1551 – volume: 9 start-page: e1003211 year: 2013 ident: BFcddis2013248_CR60 publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1003211 – volume: 171 start-page: 1172 year: 2003 ident: BFcddis2013248_CR109 publication-title: J Immunol doi: 10.4049/jimmunol.171.3.1172 – volume: 208 start-page: 50 year: 2012 ident: BFcddis2013248_CR87 publication-title: J Infect Dis doi: 10.1093/infdis/jis630 – volume: 4 start-page: e6093 year: 2009 ident: BFcddis2013248_CR117 publication-title: PLoS One doi: 10.1371/journal.pone.0006093 – volume: 286 start-page: 21083 year: 2011 ident: BFcddis2013248_CR139 publication-title: J Biol Chem doi: 10.1074/jbc.M110.195537 – volume: 7 start-page: e1000321 year: 2010 ident: BFcddis2013248_CR89 publication-title: PLoS Med doi: 10.1371/journal.pmed.1000321 – volume: 84 start-page: 2762 year: 2010 ident: BFcddis2013248_CR19 publication-title: J Virol doi: 10.1128/JVI.01350-09 – volume: 96 start-page: 293 year: 2005 ident: BFcddis2013248_CR40 publication-title: J Cell Biochem doi: 10.1002/jcb.20532 – volume: 84 start-page: 2985 year: 1987 ident: BFcddis2013248_CR113 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.84.9.2985 – volume: 8 start-page: 418 year: 2010 ident: BFcddis2013248_CR131 publication-title: Curr HIV Res doi: 10.2174/157016210793499312 – volume: 84 start-page: 5958 year: 2010 ident: BFcddis2013248_CR43 publication-title: J Virol doi: 10.1128/JVI.00161-10 – volume: 78 start-page: 6033 year: 2004 ident: BFcddis2013248_CR96 publication-title: J Virol doi: 10.1128/JVI.78.11.6033-6042.2004 – volume: 1 start-page: e99 year: 2010 ident: BFcddis2013248_CR55 publication-title: Cell Death Dis doi: 10.1038/cddis.2010.77 – ident: BFcddis2013248_CR49 – volume: 80 start-page: 10162 year: 2006 ident: BFcddis2013248_CR58 publication-title: J Virol doi: 10.1128/JVI.00249-06 – volume: 86 start-page: 9055 year: 2012 ident: BFcddis2013248_CR133 publication-title: J Virol doi: 10.1128/JVI.00793-12 – ident: BFcddis2013248_CR124 – volume: 9 start-page: 149 year: 2012 ident: BFcddis2013248_CR8 publication-title: Virol J doi: 10.1186/1743-422X-9-149 – volume: 55 start-page: 291 year: 2012 ident: BFcddis2013248_CR94 publication-title: Clin Infect Dis doi: 10.1093/cid/cis383 – reference: 21996099 - Vaccine. 2011 Nov 15;29(49):9229-38 – reference: 7561680 - J Exp Med. 1995 Oct 1;182(4):1067-77 – reference: 9055863 - Nat Med. 1997 Mar;3(3):333-7 – reference: 19805909 - J Clin Invest. 2009 Nov;119(11):3473-86 – reference: 20300007 - J Acquir Immune Defic Syndr. 2010 May 1;54(1):1-9 – reference: 19447460 - Virology. 2009 Jun 20;389(1-2):20-5 – reference: 22486585 - Curr Stem Cell Res Ther. 2012 Jul;7(4):310-7 – reference: 10381636 - Cell Death Differ. 1999 May;6(5):420-32 – reference: 23324661 - AIDS. 2013 May 15;27(8):1199-208 – reference: 12682019 - EMBO J. 2003 Apr 15;22(8):1868-77 – reference: 10837072 - Annu Rev Immunol. 2000;18:665-708 – reference: 16370391 - Curr Opin Investig Drugs. 2005 Dec;6(12):1250-8 – reference: 18692773 - Cell Host Microbe. 2008 Aug 14;4(2):134-46 – reference: 22832125 - Virology. 2012 Oct 25;432(2):505-10 – reference: 22837004 - Nature. 2012 Jul 26;487(7408):482-5 – reference: 16319923 - EMBO J. 2006 Jan 11;25(1):139-49 – reference: 3313729 - Science. 1987 Nov 6;238(4828):800-2 – reference: 16611917 - J Virol. 2006 May;80(9):4570-9 – reference: 22291913 - PLoS One. 2012;7(1):e30176 – reference: 23364796 - J Biol Chem. 2013 Mar 15;288(11):7626-44 – reference: 8751444 - Nature. 1996 Aug 22;382(6593):722-5 – reference: 2762307 - Proc Natl Acad Sci U S A. 1989 Aug;86(15):5974-8 – reference: 19609198 - AIDS. 2009 Sep 24;23(15):2047-50 – reference: 20636281 - Curr HIV Res. 2010 Sep;8(6):418-29 – reference: 23166597 - PLoS One. 2012;7(11):e48832 – reference: 23089590 - J Infect Dis. 2013 Jul;208(1):50-6 – reference: 20979453 - J Infect Dis. 2010 Dec 1;202(11):1738-48 – reference: 21531716 - J Biol Chem. 2011 Jun 24;286(25):22211-8 – reference: 19564922 - PLoS One. 2009;4(6):e6093 – reference: 18461165 - PLoS One. 2008;3(5):e2112 – reference: 23139776 - PLoS One. 2012;7(11):e48340 – reference: 17005693 - J Virol. 2006 Oct;80(20):10162-72 – reference: 23216614 - Crit Rev Immunol. 2012;32(2):173-95 – reference: 18698017 - Clin Cancer Res. 2008 Aug 15;14(16):5000-5 – reference: 16115802 - Mol Ther. 2005 Nov;12(5):900-9 – reference: 9450746 - Nature. 1998 Jan 22;391(6665):344-5 – reference: 17496894 - Nat Genet. 2007 Jun;39(6):733-40 – reference: 22550117 - Clin Infect Dis. 2012 Jul;55(2):291-300 – reference: 20133382 - Ann Oncol. 2010 Sep;21(9):1756-64 – reference: 19775907 - Cytokine. 2010 Jan;49(1):1-9 – reference: 21148083 - Blood. 2011 Mar 10;117(10):2791-9 – reference: 17881634 - Blood. 2007 Dec 15;110(13):4161-4 – reference: 18587387 - Nat Biotechnol. 2008 Jul;26(7):808-16 – reference: 16034093 - J Immunol. 2005 Aug 1;175(3):1551-7 – reference: 20154582 - AIDS. 2010 Feb 20;24(4):609-11 – reference: 8756719 - Cell. 1996 Aug 9;86(3):367-77 – reference: 20555022 - Sci Transl Med. 2010 Jun 16;2(36):36ra43 – reference: 21992606 - Retrovirology. 2011;8:80 – reference: 22802411 - J Immunol. 2012 Aug 15;189(4):1835-42 – reference: 21471244 - J Virol. 2011 Jun;85(12):6060-4 – reference: 19327974 - Curr Opin Immunol. 2009 Apr;21(2):215-23 – reference: 22802445 - J Leukoc Biol. 2012 Dec;92(6):1147-54 – reference: 19239360 - AIDS Res Hum Retroviruses. 2009 Feb;25(2):207-12 – reference: 17356300 - Intervirology. 2007;50(3):224-8 – reference: 18261236 - Retrovirology. 2008;5:19 – reference: 10553903 - Nature. 1999 Oct 28;401(6756):874-5 – reference: 19017960 - J Immunol. 2008 Dec 1;181(11):7713-20 – reference: 12874203 - J Immunol. 2003 Aug 1;171(3):1172-82 – reference: 22020221 - FEBS Lett. 2011 Nov 16;585(22):3549-54 – reference: 20837531 - Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16934-9 – reference: 22696646 - J Virol. 2012 Sep;86(17):9055-69 – reference: 21998586 - PLoS Pathog. 2011 Oct;7(10):e1002288 – reference: 22273578 - Mol Ther. 2012 Apr;20(4):849-59 – reference: 21505294 - AIDS. 2011 Jul 17;25(11):1347-56 – reference: 22555163 - AIDS. 2012 Jul 31;26(12):1473-82 – reference: 19287090 - J Clin Invest. 2009 Apr;119(4):997-1007 – reference: 20651737 - Nat Rev Cancer. 2010 Aug;10(8):561-74 – reference: 21173593 - AIDS. 2011 Jan 14;25(2):273-4 – reference: 16601680 - EMBO J. 2006 Apr 19;25(8):1690-9 – reference: 22826124 - Arch Intern Med. 2012 Sep 10;172(16):1252-5 – reference: 19380868 - Blood. 2009 Jun 18;113(25):6304-14 – reference: 21498519 - J Biol Chem. 2011 Jun 17;286(24):21083-91 – reference: 19590405 - AIDS. 2009 Sep 10;23(14):1799-806 – reference: 22406268 - Immunity. 2012 Mar 23;36(3):491-501 – reference: 15141001 - J Virol. 2004 Jun;78(11):6033-42 – reference: 21368875 - Cell Death Dis. 2010;1:e99 – reference: 15630452 - J Clin Invest. 2005 Jan;115(1):128-37 – reference: 3106982 - Proc Natl Acad Sci U S A. 1987 May;84(9):2985-9 – reference: 20357084 - J Virol. 2010 Jun;84(12):5958-74 – reference: 21051598 - Science. 2010 Dec 10;330(6010):1551-7 – reference: 15046251 - Curr HIV Res. 2003 Jul;1(3):261-74 – reference: 1530997 - Am J Pathol. 1992 Jan;140(1):15-22 – reference: 22875804 - J Immunol. 2012 Sep 15;189(6):2879-89 – reference: 22185562 - Virol J. 2011;8:554 – reference: 23195410 - Genomics. 2013 Feb;101(2):101-12 – reference: 3782153 - J Biol Chem. 1986 Dec 25;261(36):17057-61 – reference: 10229227 - Nat Med. 1999 May;5(5):512-7 – reference: 16088937 - J Cell Biochem. 2005 Oct 1;96(2):293-304 – reference: 18097036 - J Immunol. 2008 Jan 1;180(1):350-60 – reference: 21626033 - Cancer Immunol Immunother. 2011 Aug;60(8):1173-80 – reference: 23392463 - J Acquir Immune Defic Syndr. 2013 May 1;63(1):101-4 – reference: 15709033 - J Virol. 2005 Mar;79(5):3139-45 – reference: 21945613 - Biochem Biophys Res Commun. 2011 Oct 14;414(1):20-4 – reference: 18516228 - PLoS Pathog. 2008 May;4(5):e1000018 – reference: 21430059 - J Virol. 2011 Jun;85(11):5384-93 – reference: 17442709 - J Virol. 2007 Jul;81(13):6947-56 – reference: 8145919 - Neurology. 1994 Mar;44(3 Pt 1):481-7 – reference: 9024664 - Nature. 1997 Feb 13;385(6617):645-9 – reference: 10975846 - J Immunol. 2000 Sep 15;165(6):3293-300 – reference: 22421787 - Nat Rev Immunol. 2012 Apr;12(4):306-15 – reference: 22553251 - Sci Transl Med. 2012 May 2;4(132):132ra53 – reference: 23370291 - Hum Vaccin Immunother. 2013 May;9(5):993-1001 – reference: 9811703 - J Virol. 1998 Dec;72(12):9698-705 – reference: 8096068 - Nature. 1993 Mar 25;362(6418):359-62 – reference: 22139420 - Nature. 2012 Jan 5;481(7379):81-4 – reference: 19213682 - N Engl J Med. 2009 Feb 12;360(7):692-8 – reference: 20942961 - Virol J. 2010;7:266 – reference: 22814509 - Nat Rev Immunol. 2012 Aug;12(8):607-14 – reference: 19062316 - Immunity. 2008 Dec 19;29(6):1009-21 – reference: 23516360 - PLoS Pathog. 2013 Mar;9(3):e1003211 – reference: 22134777 - Mol Biosyst. 2012 Apr;8(4):985-93 – reference: 22866982 - Virol J. 2012;9:149 – reference: 17237230 - J Biol Chem. 2007 Mar 16;282(11):8207-18 – reference: 3374584 - Nature. 1988 Jun 2;333(6172):426-31 – reference: 21284992 - Virology. 2011 Mar 15;411(2):344-54 – reference: 16277553 - PLoS Biol. 2005 Dec;3(12):e404 – reference: 20042498 - J Virol. 2010 Mar;84(6):2762-73 – reference: 12163598 - J Virol. 2002 Sep;76(17):8776-86 – reference: 20711481 - PLoS Med. 2010;7(8). pii: e1000321. doi: 10.1371/journal.pmed.1000321 – reference: 9449720 - J Exp Med. 1998 Feb 2;187(3):403-13 – reference: 8791590 - Science. 1996 Sep 27;273(5283):1856-62 – reference: 21402072 - FEBS Lett. 2011 Apr 6;585(7):1103-11 – reference: 9144289 - Nature. 1997 May 8;387(6629):183-8 – reference: 18260759 - J Infect Dis. 2008 Mar 1;197(5):714-20 – reference: 19486542 - Retrovirology. 2009;6:52 – reference: 20812891 - Expert Opin Emerg Drugs. 2011 Mar;16(1):59-70 – reference: 15767451 - J Virol. 2005 Apr;79(7):4510-3 – reference: 21849486 - Blood. 2011 Nov 3;118(18):4817-28 – reference: 21859711 - J Biol Chem. 2011 Oct 14;286(41):35742-54 |
SSID | ssj0000330256 |
Score | 2.2577858 |
SecondaryResourceType | review_article |
Snippet | Recent cases of successful control of human immunodeficiency virus (HIV) by bone marrow transplant in combination with suppressive antiretroviral therapy (ART)... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e718 |
SubjectTerms | 631/326/596/2558 631/80/82/23 692/699/255/1901 Animals Anti-HIV Agents - pharmacology Anti-HIV Agents - therapeutic use Antibodies Apoptosis Biochemistry Biomedical and Life Sciences CD4-Positive T-Lymphocytes - physiology CD4-Positive T-Lymphocytes - virology Cell Biology Cell Culture Cell death Genetic Therapy HIV Infections - immunology HIV Infections - therapy HIV-1 - physiology Host-Pathogen Interactions Human immunodeficiency virus Humans Immunology Immunotherapy Life Sciences Review Virus Latency |
SummonAdditionalLinks | – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEA5aEbyIb-uLCIJetqab7Gb3IFLEUoV6stLbkldRKFvtA-2_d2Yf1VoVdk-ZQDLJZL7JTGYIOWOWK6Oc8JivtSe0AJGSofM4tzbUDCSK4QPn9kPY6oj7btD9in8qGDj61bTDelKdYb_28Ta9BoG_yp-MR5cGI28wSovXfBEtkxXQShKFtF1A_exUBsMd1HuZt3Gh27xeWgCbizGTPxynmT5qbpD1AkjSRr7ym2TJpVtkNS8tOd0mjQa6waEnxat5ahHpUSw__K6mI6rgS2mZT5yOB9RMho627p5oGZ2V7pBO8_bxpuUV5RI8EwRyDEZgz2cK4JEF1BHGVvQiIVSkmZCBAdFlOtY65ACnmbZSQgNzcLhJrrRR8PNdUkkHqdsnNO4JY3uhiwID5oYPMsxih3XSYx5H1hdV4pXMSkyRSxxLWvSTzKfNoyRjboLMTYC5VXI-o3_Ns2j8SXlU8j4pN0NSl2B3oX-yXiWns2aQA-SgSt1gAjSAtGJQyTL4h0bGYM0CBIYJ7OXLORsOQBcR-j6rEjm30DMCzMM935K-PGf5uLnEOyEY20W5Jb4N_ddZHvw_y0Oy5mdVNzAq-IhUxsOJOwbsM9Yn2ab-BNaiA3s priority: 102 providerName: Scholars Portal – databaseName: SpringerOpen Free (Free internet resource, activated by CARLI) dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS8MwEA86EXwRv61OiSDoSzVr0qZ9HMMxBX1ysreSr6EgnbgO2X_vXb9w8wOhfcoFLpe75ne56x0h58xyZZQTPgu09oUWYFIycj7n1kaagUUx_MH5_iEaDMXdKBxVjuK0SqssS1oWn-k6O-zaYHYNZmLxq0DEq2QNy7ajRveiXnOnwsA5hyO8rs3I46Vpi2fPN0D5PS9yKThanDn9LbJZgUXaLdnbJisu2yHrZfvI-S7pdjHUDTMpXr9Ti2iOYovhDzWfUgVPRuua4TSfUAPrpYPbJ1pnYGV7ZNi_eewN_Kolgm_CUObg6I0DpgACWUAWUWLFOBZCxZoJGRowT6YTrSMOkJlpKyUMMAcfMMmVNgpevk9a2SRzh4QmY2HsOHJxaMClCMBOWeKwF3rCk9gGwiN-LazUVPXCsW3Fa1rErXmcFsJNUbgpCNcjFw39W1kp41fKdi37tLKYadqR4FthDLLjkbNmGHQdJagyN5kBDaCpBI5dGf5BIxPwWAHmwgIOyu1s2AF4IqIgYB6RCxvdEGCt7cWR7OW5qLnNJd77AG-XtUp8Yf3HVR79n_SYbARFlw3MAm6TVv4-cyeAdXJ9Wij4Jxnw_cI priority: 102 providerName: Springer Nature |
Title | Altering cell death pathways as an approach to cure HIV infection |
URI | https://link.springer.com/article/10.1038/cddis.2013.248 https://www.ncbi.nlm.nih.gov/pubmed/23846220 https://www.proquest.com/docview/1786208991 https://www.proquest.com/docview/1399934175 https://www.proquest.com/docview/1790941504 https://pubmed.ncbi.nlm.nih.gov/PMC3730421 |
Volume | 4 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3rSyMxEB885eC-iI9T66NEELwve8ZNdrP7Sdai1IIieh79tuRVFGSrtkX8753Z7q5voQ9oZiGZZJJfZqbzA9jhTmirvQx4aEwgjUSTUrEPhHAuNhwtitMfnE_P4u6V7PWjfuVwG1VplfWeWG7UbmjJR763rxB7U4xq_-DuPiDWKIquVhQaP2COSpdRSpfqq8bHwvGyjkd6XatRJHuWknQooUv8DYny5_VZ9AFgfsyTfBcsLc-g4wWYr8Ajy6azvQgzvliCn1M6yadlyDIKfeOTjNzxzBG6Y0Q5_KifRkzjq2B1DXE2HjI7efCse_Kf1RlZxW-4Oj761-kGFUVCYKNIjfHiNwi5RkjkEGnEqZODREqdGC5VZNFcuUmNiQVCaG6cUtjAPW5oSmhjNb7FCswWw8KvAUsH0rpB7JPI4hUjRLvlqSdu9FSkiQtlC4JaWbmt6ocTjcVtXsaxRZKXys1JuTkqtwW7jfzdtHLGl5Kbte7zyoJG-ct8t2C7aca1TxrUhR9OUAbRVYrHsIq-kVEp3mAR9uIAVqfT2XQH4YqMw5C3QL2Z6EaAam-_bSlurssa3EKRHwj79qdeEq-6_uko178f5Qb8CkumDcoE3oTZ8cPEbyHeGZt2uajbMJdlvcsefh8enZ1f4K-duNMufQj4eSqTZ0onBjc |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgheEN8UBhgJBC9hnu3EyQNCBTa1bKsQ2tDegr8qJk3pWFtN_af4G7lL4rAx2Nuk5MmXyD7f2b_zne8AXnIvjTNBJVxYmyirUKV0FhIpvc8sR43idMF5d5wN99Xng_RgBX7FuzAUVhnXxHqh9lNHZ-TrGxqxN_moNt4f_0yoahR5V2MJjUYstsPyFE222bvRJ5zfV0Jsbe59HCZtVYHEpameo600EdwgivC4OWeFV5NcKZNbrnTqUMK5LazNJKJObr3W2MADrgFaGusMvhL_ew1WlURTpgerHzbHX752pzpcSgIRMTukzNcdhQVRCJl8K6jI0Nnd7wKkvRiZ-Zd7tt71tm7DrRauskEjX3dgJVR34XpTwHJ5DwYDcrbjl4wcAMwTnmRU5PjULGfM4FOxmLWczafMLU4CG46-sRgDVt2H_Sth3wPoVdMqPAJWTJTzkyzkqUOjRuBKwYtA1dgLWeReqD4kkVmlazOWU-GMo7L2nMu8rJlbEnNLZG4fXnf0x02ujv9SrkXel63Ozso_EtaHF10zahtx0FRhukAaxHMFbvw6vYRGF2gzI9DGATxsprPrDgIklQnB-6DPTXRHQNm-z7dUhz_qrN9S08kT9u1NFIkzXf_nKB9fPsrncGO4t7tT7ozG20_gpqjrfFAc8hr05ieL8BTR1tw-a0Wcwfer1qrf-Vo-tA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NIRAviG8KA4wEgpdQ13bi5AGhilG1DCYeGOpb8FcEEkrH2mrqv8Zfx10Sh43B3ialT75G9vnO_tl3uR_AM-6lcSaohAtrE2UVupTOQiKl95nl6FGcPnD-uJ9ND9T7eTrfgl_xWxhKq4xrYrNQ-4WjO_LhSCP2phjVaFh1aRGfdidvDn8mxCBFkdZIp9GayF7YHOPxbfl6totz_VyIybvPb6dJxzCQuDTVKzw3VYIbRBQeN-qs8KrKlTK55UqnDq2d28LaTCIC5dZrjQ084HqgpbHO4E_iey_BZS3TEfmYnuv-fodLSXAi1omU-dBRghAlk8lXguiGTu6DZ8Dt2RzNvwK1zf43uQHXO-DKxq2l3YStUN-CKy2V5eY2jMcUdsd_MgoFME_IkhHd8bHZLJnBp2axfjlbLZhbHwU2nX1hMRusvgMHF6K8u7BdL-pwH1hRKeerLOSpw-ONwDWDF4F42QtZ5F6oASRRWaXrapcThcaPsomhy7xslFuScktU7gBe9PKHbdWO_0ruRN2Xnfcuyz-2NoCnfTP6HWnQ1GGxRhlEdgVCAJ2eI6MLPD0j5MYB3Guns-8OQiWVCcEHoE9NdC9Adb9Pt9TfvzX1v6WmOyjs28toEie6_s9RPjh_lE_gKvpS-WG2v_cQromG8IMSkndge3W0Do8Qdq3s48a-GXy9aIf6DT05QYQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Altering+cell+death+pathways+as+an+approach+to+cure+HIV+infection&rft.jtitle=Cell+death+%26+disease&rft.au=Badley%2C+A+D&rft.au=Sainski%2C+A&rft.au=Wightman%2C+F&rft.au=Lewin%2C+S+R&rft.date=2013-07-01&rft.pub=Springer+Nature+B.V&rft.eissn=2041-4889&rft.volume=4&rft.spage=e718&rft_id=info:doi/10.1038%2Fcddis.2013.248&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=4042531961 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-4889&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-4889&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-4889&client=summon |